<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals - Holme, Ø - 2013 | Cochrane Library</title> <meta content="Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals - Holme, Ø - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009259.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals - Holme, Ø - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009259.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009259.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals" name="citation_title"/> <meta content="Øyvind Holme" name="citation_author"/> <meta content="Sorlandet Hospital Kristiansand" name="citation_author_institution"/> <meta content="oyvind.holme@sshf.no" name="citation_author_email"/> <meta content="Michael Bretthauer" name="citation_author"/> <meta content="University of Oslo" name="citation_author_institution"/> <meta content="Atle Fretheim" name="citation_author"/> <meta content="Norwegian Knowledge Centre for the Health Services" name="citation_author_institution"/> <meta content="Jan Odgaard‐Jensen" name="citation_author"/> <meta content="Norwegian Knowledge Centre for the Health Services" name="citation_author_institution"/> <meta content="Geir Hoff" name="citation_author"/> <meta content="Telemark Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD009259.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/10/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009259.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009259.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009259.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Occult Blood; *Sigmoidoscopy [adverse effects, mortality]; Colonic Neoplasms [*diagnosis, mortality]; Colonoscopy [adverse effects, mortality]; Guaiac; Indicators and Reagents; Randomized Controlled Trials as Topic; Rectal Neoplasms [*diagnosis, mortality]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009259.pub2&amp;doi=10.1002/14651858.CD009259.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="1pyM3CVc";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009259\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009259\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","hr","fr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009259.pub2",title:"Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals",firstPublishedDate:"Oct 1, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Colorectal Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1pyM3CVc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009259.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009259.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009259.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009259.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009259.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009259.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009259.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009259.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009259.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009259.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5932 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009259.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-sec-0075"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/appendices#CD009259-sec-0084"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/table_n/CD009259StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/table_n/CD009259StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#CD009259-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Øyvind Holme</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#CD009259-cr-0003">Michael Bretthauer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#CD009259-cr-0004">Atle Fretheim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#CD009259-cr-0005">Jan Odgaard‐Jensen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information#CD009259-cr-0006">Geir Hoff</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information/en#CD009259-sec-0105">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 October 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009259.pub2">https://doi.org/10.1002/14651858.CD009259.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009259-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009259-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009259-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009259-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009259-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009259-abs-0002">繁體中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009259-abs-0001" lang="en"> <section id="CD009259-sec-0001"> <h3 class="title" id="CD009259-sec-0001">Background</h3> <p>Colorectal cancer is the third most frequent cancer in the world. As the sojourn time for this cancer is several years and a good prognosis is associated with early stage diagnosis, screening has been implemented in a number of countries. Both screening with faecal occult blood test and flexible sigmoidoscopy have been shown to reduce mortality from colorectal cancer in randomised controlled trials. The comparative effectiveness of these tests on colorectal cancer mortality has, however, never been evaluated, and controversies exist over which test to choose. </p> </section> <section id="CD009259-sec-0002"> <h3 class="title" id="CD009259-sec-0002">Objectives</h3> <p>To compare the effectiveness of screening for colorectal cancer with flexible sigmoidoscopy to faecal occult blood testing. </p> </section> <section id="CD009259-sec-0003"> <h3 class="title" id="CD009259-sec-0003">Search methods</h3> <p>We searched MEDLINE and EMBASE (November 16, 2012), the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 11) and reference lists for eligible studies. </p> </section> <section id="CD009259-sec-0004"> <h3 class="title" id="CD009259-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing screening with flexible sigmoidoscopy or faecal occult blood testing to each other or to no screening. Only studies reporting mortality from colorectal cancer were included. Faecal occult blood testing had to be repeated (annually or biennially). </p> </section> <section id="CD009259-sec-0005"> <h3 class="title" id="CD009259-sec-0005">Data collection and analysis</h3> <p>Data retrieval and assessment of risk of bias were performed independently by two review authors. Standard meta‐analyses using a random‐effects model were conducted for flexible sigmoidoscopy and faecal occult blood testing (FOBT) separately and we calculated relative risks with 95% confidence intervals (CI). We used a Bayesian approach (a contrast‐based network meta‐analysis method) for indirect analyses and presented the results as posterior median relative risk with 95% credibility intervals. We assessed the quality of evidence using GRADE. </p> </section> <section id="CD009259-sec-0006"> <h3 class="title" id="CD009259-sec-0006">Main results</h3> <p>We identified nine studies comprising 338,467 individuals randomised to screening and 405,919 individuals to the control groups. Five studies compared flexible sigmoidoscopy to no screening and four studies compared repetitive guaiac‐based FOBT (annually and biennially) to no screening. We did not consider that study risk of bias reduced our confidence in our results. We did not identify any studies comparing the two screening methods directly. When compared with no screening, colorectal cancer mortality was lower with flexible sigmoidoscopy (relative risk 0.72; 95% CI 0.65 to 0.79, high quality evidence) and FOBT (relative risk 0.86; 95% CI 0.80 to 0.92, high quality evidence). In the analyses based on indirect comparison of the two screening methods, the relative risk of dying from colorectal cancer was 0.85 (95% credibility interval 0.72 to 1.01, low quality evidence) for flexible sigmoidoscopy screening compared to FOBT. No complications occurred after the FOBT test itself, but 0.03% of participants suffered a major complication after follow‐up. Among more than 60,000 flexible sigmoidoscopy screening procedures and almost 6000 work‐up colonoscopies, a major complication was recorded in 0.08% of participants. Adverse event data should be interpreted with caution as the reporting of adverse effects was incomplete. </p> </section> <section id="CD009259-sec-0007"> <h3 class="title" id="CD009259-sec-0007">Authors' conclusions</h3> <p>There is high quality evidence that both flexible sigmoidoscopy and faecal occult blood testing reduce colorectal cancer mortality when applied as screening tools. There is low quality indirect evidence that screening with either approach reduces colorectal cancer deaths more than the other. Major complications associated with screening require validation from studies with more complete reporting of harms. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009259-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009259-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009259-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009259-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009259-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009259-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009259-abs-0008">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009259-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009259-abs-0004" lang="en"> <h3>Comparison of two methods used in screening for colorectal cancer</h3> <p>Cancer in the large intestine (colon) and rectum is one of the most frequent cancers in developed countries. The disease develops from benign lesions over a time span of about 10 years. If the lesion has turned into cancer, the prognosis is far better if the disease is detected at an early stage. Screening and detection for early cancers and benign precursors may therefore reduce the number of deaths caused by this disease. Cancers and benign precursors may bleed, and the blood can be detected in the stool by specific tests, the so‐called faecal occult blood tests (FOBT). If the test is positive (that is blood is detected), the person will be offered a colonoscopy to find the source of bleeding. Unfortunately, FOBT fails to discover a considerable number of cancers and precursor lesions. Therefore, endoscopic examination of the rectum and lower large intestine (the sigmoid colon) has been advocated (called flexible sigmoidoscopy). Flexible sigmoidoscopy is performed with a flexible instrument inserted through the anus and introduced about 50 centimetres into the lower large intestine after cleansing with a small enema. This allows direct visual inspection of the interior wall of the intestine, and benign lesions and malignant tumours may be detected. Benign lesions may be removed in the same session without anaesthesia and without any discomfort for the patient, and a follow‐up colonoscopy may be offered. </p> <p>The purpose of this review was to compare the two screening methods (FOBT and flexible sigmoidoscopy) in their ability to reduce the number of deaths due to cancer in the large intestine and rectum. </p> <p>We identified four trials which compared FOBT to no screening and five trials which compared flexible sigmoidoscopy to no screening. No studies compared the two methods directly. Mortality from colorectal cancer was reduced with FOBT screening and screening with flexible sigmoidoscopy. When we compared the two methods, we could not conclude that one was better than the other. </p> <p>No complications occurred after the FOBT test itself, but 0.03% of participants suffered a major complication after follow‐up. Among more than 60,000 flexible sigmoidoscopy screening procedures and almost 6000 work‐up colonoscopies, a major complication was recorded in 0.08% of participants. These findings should be interpreted with caution as the reporting of adverse effects was incomplete. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009259-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009259-sec-0079"></div> <h3 class="title" id="CD009259-sec-0080">Implications for practice</h3> <section id="CD009259-sec-0080"> <p>There is high quality evidence that screening by guaiac‐based FOBT and flexible sigmoidoscopy both reduce mortality due to colorectal cancer. Neither FOBT nor flexible sigmoidoscopy was shown to reduce all‐cause mortality. We are unable to draw definitive conclusions with regard to the frequency or severity of physical adverse events attributable to screening due to incomplete reporting of these data. Flexible sigmoidoscopy reduces CRC incidence while the results for FOBT are inconclusive </p> <p>In the absence of direct evidence comparing the two screening approaches, we are not certain as to whether one screening tool reduces colorectal cancer deaths more than the other. There was low quality evidence of a lower rate of CRC mortality associated with flexible sigmoidoscopy. The evidence underlying our estimates is too weak to draw any definitive conclusion about the relative effectiveness of the two screening methods. . </p> <p>The effectiveness of a screening programme is heavily dependent on adherence to screening and should be assessed in pilot studies prior to implementation of a screening programme, as the population's acceptance of the screening modality may vary among different countries (<a href="./references#CD009259-bbs2-0067" title="SegnanN , SenoreC , AndreoniB , ArrigoniA , BisantiL , CardelliA , et al. SCORE2 Working Group‐Italy. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Journal of the National Cancer Institute2005;97(5):347‐57. [Pubmed: 15741571] ">Segnan 2005</a>; <a href="./references#CD009259-bbs2-0055" title="HolL , vanLeerdamME , vanBallegooijenM , vanVuurenAJ , vanDekkenH , ReijerinkJC , et al. Screening for colorectal cancer: randomised trial comparing guaiac‐based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut2010;59(1):62‐8. [PUBMED: 19671542] ">Hol 2010</a>). Available resources, both financial and human, also have to be considered. Cost‐benefit analyses have to be performed in the context of each country, as assumptions in such analyses may differ substantially between countries and make conclusions non‐generalizable (<a href="./references#CD009259-bbs2-0058" title="Lansdorp‐VogelaarI , KnudsenAB , BrennerH . Cost‐effectiveness of colorectal cancer screening ‐ an overview. Best Practice &amp; Research. Clinical Gastroenterology2010;24(4):439‐49. [PUBMED: 20833348] ">Lansdorp‐Vogelaar 2010</a>). </p> </section> <h3 class="title" id="CD009259-sec-0081">Implications for research</h3> <section id="CD009259-sec-0081"> <p>A number of research questions remain to be answered. We do not know the optimal age for screening and whether this differs between screening modalities. A colonoscopy screening study from Poland suggests that the diagnostic yield of advanced adenomas differs with sex and age, and different screening strategies may be warranted for men and women (<a href="./references#CD009259-bbs2-0063" title="RegulaJ , RupinskiM , KraszewskaE , PolkowskiM , PachlewskiJ , OrlowskaJ , et al. Colonoscopy in colorectal‐cancer screening for detection of advanced neoplasia. The New England Journal of Medicine2006;355(18):1863‐72. [PUBMED: 17079760] ">Regula 2006</a>). Guaiac‐based FOBTs are the only FOBTs with proven effectiveness on CRC mortality. Immunologic FOBTs (FIT) have higher sensitivity for CRC (61% to 91%) and advanced neoplasia (27% to 67%) than the guaiac‐based tests (25% to 38% and 16% to 31%, respectively) and have only slightly lower specificity (91% to 98% versus 98% to 99%, respectively) (<a href="./references#CD009259-bbs2-0071" title="vanDamL , KuipersEJ , vanLeerdamME . Performance improvements of stool‐based screening tests. Best Practice &amp; Research. Clinical Gastroenterology2010;24(4):479‐92. [PUBMED: 20833351] ">van Dam 2010</a>). The test procedure with FIT is also more convenient for the person to be screened, who only has to provide faeces from one passage of stool instead of two samples from three consecutive days, and no dietary restrictions are necessary. These advantages have been shown to increase adherence to screening and the diagnostic yield of advanced adenomas (<a href="./references#CD009259-bbs2-0055" title="HolL , vanLeerdamME , vanBallegooijenM , vanVuurenAJ , vanDekkenH , ReijerinkJC , et al. Screening for colorectal cancer: randomised trial comparing guaiac‐based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut2010;59(1):62‐8. [PUBMED: 19671542] ">Hol 2010</a>), but repeated FIT has to our knowledge never been evaluated with respect to CRC mortality. It would be of great interest to compare FIT to flexible sigmoidoscopy in a randomised trial with mortality from CRC as the outcome. The possible 'health certificate effect' (<a href="./references#CD009259-bbs2-0070" title="Stewart‐BrownS , FarmerA . Screening could seriously damage your health. BMJ (Clinical research ed.)1997; Vol. 314, issue 7080:533‐4. [PUBMED: 9055702] ">Stewart‐Brown 1997</a>) among screened persons indicated in the NORCCAP trial may have an important impact if screening is introduced in the population and should be addressed in future studies (<a href="./references#CD009259-bbs2-0014" title="LarsenIK , GrotmolT , AlmendingenK , HoffG . Impact of colorectal cancer screening on future lifestyle choices: a three‐year randomized controlled trial. Clinical Gastroenterology and Hepatology2007;5(4):477‐83. [PUBMED: 17363335] ">Larsen 2007</a>). Ascertainment and reporting of adverse events is an important priority for future research in this area. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009259-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009259-sec-0029"></div> <div class="table" id="CD009259-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Screening for colorectal cancer with flexible sigmoidoscopy or faecal occult blood test</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Flexible sigmoidoscopy or faecal occult blood testing compared with care as usual for colorectal cancer screening</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: Asymptomatic individuals</b> </p> <p><b>Settings: Participants recruited among volunteers or randomly chosen from public registries</b> </p> <p><b>Intervention: Flexible sigmoidoscopy once only or repeated faecal occult blood testing</b> </p> <p><b>Comparison: Care as usual</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks<sup>1</sup> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No screening</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Screening group</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC Mortality ‐ Flexible sigmoidoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> <br/> (5 to 6) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,72</b> (0.65 to 0.79) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414,744<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC Mortality ‐ Faecal occult blood testing</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> <br/> (6 to 7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,86</b> (0.80 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329,642<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC incidence ‐ Flexible sigmoidoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> <br/> (15 to 18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,82</b> (0.73 to 0.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414,744<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC incidence ‐ Faecal occult blood testing</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (18 to 20 ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,95</b> (0,88 to 1,02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329,536<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause Mortality ‐ Flexible sigmoidoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>254 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>249 per 1000</b> <br/> (241 to 257 ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,98</b> (0.95 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>364,827<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause Mortality ‐ Faecal occult blood testing</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>254 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>254 per 1000</b> <br/> (251 to 257) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1,00</b> (0,99 to 1,01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329,642<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>CRC:</b> Colorectal cancer </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Assumed risk is computed by combining events and participants in the control groups in all trials. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). </p> <p><sup>2</sup> Evidence downgraded one level due to heterogeneity between trials. This heterogeneity may be explained by shorter follow‐up of the Norwegian NORCCAP trial, but other explanations like study design cannot be ruled out. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009259-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009259-sec-0030"></div> <section id="CD009259-sec-0031"> <h3 class="title" id="CD009259-sec-0031">Description of the condition</h3> <p>With more than 550,000 annual deaths, colorectal cancer (CRC) is a major health problem in industrialized countries. CRC is the most frequent malignant disease diagnosed in Europe (<a href="./references#CD009259-bbs2-0050" title="FerlayJ , ParkinDM , Steliarova‐FoucherE . Estimates of cancer incidence and mortality in Europe in 2008. European Journal of Cancer2010;46(4):765‐81. [PUBMED: 20116997] ">Ferlay 2010</a>) and the third most frequent cancer in the United States (<a href="./references#CD009259-bbs2-0056" title="JemalA , SiegelR , WardE , HaoY , XuJ , ThunMJ . Cancer statistics, 2009. CA: a Cancer Journal for Clinicians2009;59(4):225‐49. [PUBMED: 19474385] ">Jemal 2009</a>). Most cases of CRC develop in so‐called average risk individuals, that is in individuals without any known CRC risk factors. To date, the lifetime risk for colorectal cancer for average‐risk individuals in industrialized countries is about 5%. Five‐year survival of people with colorectal cancer exceeds 90% if the disease is diagnosed at an early stage, but only about 60% for patients with lymph node involvement and under 10% if distant organ metastases are present (<a href="./references#CD009259-bbs2-0064" title="RiesL , MelbertD , KrapchoM , StinchcombD , HowladerN , HornerM , et al. SEER Cancer Statistics Review, 1975‐2005. http://seer.cancer.gov/csr/1975‐2005/. ">Ries 2007</a>). </p> </section> <section id="CD009259-sec-0032"> <h3 class="title" id="CD009259-sec-0032">Description of the intervention</h3> <p>Testing for faecal occult blood has been extensively studied, and a variety of commercial tests are available. These tests are based on either detecting peroxidase activity of the haeme moiety of the haemoglobin molecule (guaiac tests, FOBT) or immunochemical methods (faecal immunological test, FIT) that are specific towards the globin part of the human haemoglobin. </p> <p>Screening for CRC has been implemented in a number of countries. Testing for faecal occult blood (FOBT), flexible sigmoidoscopy and colonoscopy are used as screening tools. The only two modalities that have been tested in randomised trials are FOBT and flexible sigmoidoscopy, but despite this, colonoscopy is regarded the gold standard in CRC screening. The obvious advantage of colonoscopy as a screening tool is the direct visualisation of the entire colonic mucosa, but this may be a false reassurance. Several case‐control studies have indicated that colonoscopy does not affect CRC mortality and the presence of advanced adenomas in the colon proximal to the splenic flexure (<a href="./references#CD009259-bbs2-0045" title="BaxterNN , GoldwasserMA , PaszatLF , SaskinR , UrbachDR , RabeneckL . Association of colonoscopy and death from colorectal cancer. Annals of Internal Medicine2009;150(1):1‐8. [PUBMED: 19075198] ">Baxter 2009</a>; <a href="./references#CD009259-bbs2-0047" title="BrennerH , HoffmeisterM , ArndtV , StegmaierC , AltenhofenL , HaugU . Protection from right‐ and left‐sided colorectal neoplasms after colonoscopy: population‐based study. Journal of the National Cancer Institute2010;102(2):89‐95. [PUBMED: 20042716] ">Brenner 2010</a>). </p> </section> <section id="CD009259-sec-0033"> <h3 class="title" id="CD009259-sec-0033">How the intervention might work</h3> <p>As clinical symptoms develop late in the course of the disease, early detection is often not achieved in individuals with symptoms. It is believed that the majority of colorectal cancers develop from benign precursor lesions, the so‐called adenomatous polyps or adenomas, through a series of genetic changes (adenoma‐carcinoma sequence) during a time interval of at least five to 10 years (<a href="./references#CD009259-bbs2-0060" title="MutoT , BusseyHJ , MorsonBC . The evolution of cancer of the colon and rectum. Cancer1975;36(6):2251‐70. [PUBMED: 1203876] ">Muto 1975</a>; <a href="./references#CD009259-bbs2-0072" title="VogelsteinB , FearonER , HamiltonSR , KernSE , PreisingerAC , LeppertM , et al. Genetic alterations during colorectal‐tumor development. The New England Journal of Medicine1988;319(9):525‐32. [PUBMED: 2841597] ">Vogelstein 1988</a>). Therefore, CRC is considered a good target for screening. </p> </section> <section id="CD009259-sec-0034"> <h3 class="title" id="CD009259-sec-0034">Why it is important to do this review</h3> <p>As the FOBT and flexible sigmoidoscopy have never been directly compared by means of CRC mortality in prospective studies, uncertainty still exists regarding which test to choose. Both tests have limitations. For example, sensitivity for both CRC and adenoma detection is lower for FOBT compared to flexible sigmoidoscopy, but only half of the colon is examined with the latter, which means that about one third of neoplasias (CRCs and adenomas) that are located in the proximal colon may be missed (<a href="./references#CD009259-bbs2-0043" title="AndersonJC , AlpernZ , MessinaCR , LaneB , HubbardP , GrimsonR , et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. The American Journal of Gastroenterology2004;99(3):472‐7. [PUBMED: 15056088] ">Anderson 2004</a>). FOBT is performed at home without any absenteeism from work, and reading of the tests may be automated (FIT only). Flexible sigmoidoscopy is labour demanding, and its invasive nature may lead to lower compliance with screening (<a href="./references#CD009259-bbs2-0055" title="HolL , vanLeerdamME , vanBallegooijenM , vanVuurenAJ , vanDekkenH , ReijerinkJC , et al. Screening for colorectal cancer: randomised trial comparing guaiac‐based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut2010;59(1):62‐8. [PUBMED: 19671542] ">Hol 2010</a>) and higher complication rates. </p> <p>There are four large randomised, controlled studies which have established the effectiveness of FOBT (<a href="./references#CD009259-bbs2-0017" title="MandelJS , BondJH , ChurchTR , SnoverDC , BradleyGM , SchumanLM , et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England Journal of Medicine1993;328(19):1365‐71. [PUBMED: 8474513] ">Mandel 1993</a>; <a href="./references#CD009259-bbs2-0004" title="HardcastleJD , ChamberlainJO , RobinsonMH , MossSM , AmarSS , BalfourTW , et al. Randomised controlled trial of faecal‐occult‐blood screening for colorectal cancer. Lancet1996;348(9040):1472‐7. [PUBMED: 8942775] ">Hardcastle 1996</a>; <a href="./references#CD009259-bbs2-0011" title="KronborgO , FengerC , OlsenJ , JorgensenOD , SondergaardO . Randomised study of screening for colorectal cancer with faecal‐occult‐blood test. Lancet1996;348(9040):1467‐71. [PUBMED: 8942774] ">Kronborg 1996</a>; <a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>) and the results have been pooled in a Cochrane review (<a href="./references#CD009259-bbs2-0053" title="HewitsonP , GlasziouP , IrwigL , TowlerB , WatsonE . Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD001216.pub2; PUBMED: 17253456] ">Hewitson 2007</a>). This review showed a reduction in mortality from CRC by 16% due to screening, but no reduction in CRC incidence or all‐cause mortality. Until recently, flexible sigmoidoscopy had only been evaluated in one small‐scale randomised controlled trial. This study from Norway showed an 80% decrease in CRC incidence in the screening group after 13 years, but a disturbing 57% increase in all‐cause mortality (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>) compared to a no‐screening control group. In the last years, four large randomised trials of CRC screening by flexible sigmoidoscopy have been published (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>; <a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>; <a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>; <a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>). A reduction in CRC mortality of 22% to 31% was observed in the screening groups compared to the no‐screening control groups. The three latter studies also found a reduced incidence of CRC by 18% to 23%, respectively, but no effect on all‐cause mortality. </p> <p>Therefore, whether to implement the low‐cost non‐invasive FOBT or the invasive and relatively resource‐demanding flexible sigmoidoscopy is an area of controversy. The scope of this review is to compare these modalities when applied as screening tools in asymptomatic individuals in randomised controlled trials. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009259-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009259-sec-0035"></div> <p>The purpose of this review was to identify randomised controlled trials of FOBT or flexible sigmoidoscopy as a CRC screening modality in an asymptomatic population and to compare the effectiveness on colorectal cancer (CRC) mortality for these two methods. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009259-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009259-sec-0036"></div> <section id="CD009259-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009259-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials of CRC screening reporting mortality from CRC in individuals invited for screening with flexible sigmoidoscopy versus FOBT or with any of these versus no screening. As FOBT screening requires repetitive testing, only studies investigating FOBT that included repetitive stool‐testing (annually or biennially) were considered. Studies that were only reported as abstracts without full‐paper publication were not included. There was no restriction with regard to publication language. Data from trials that were published on several occasions due to increasing length of follow‐up were analysed once only, and only data from the latest publication were included in the main analyses. Quasi‐randomised trials were not included. </p> </section> <section id="CD009259-sec-0039"> <h4 class="title">Types of participants</h4> <p>Adult (18 years and older) asymptomatic individuals participating in a CRC screening trial with either FOBT or flexible sigmoidoscopy. Participants could be recruited either as volunteers or identified through population or general practitioners' registries. </p> </section> <section id="CD009259-sec-0040"> <h4 class="title">Types of interventions</h4> <p>CRC screening with FOBT or flexible sigmoidoscopy. For FOBT, both guaiac‐based and immunological tests were included. The guaiac test slides were or were not rehydrated. For the flexible sigmoidoscopy trials, trials using rigid endoscopes were excluded. </p> </section> <section id="CD009259-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD009259-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009259-list-0001"> <li> <p>CRC mortality</p> </li> </ul> </p> <p>Studies not reporting CRC mortality were excluded from the review.</p> </section> <section id="CD009259-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009259-list-0002"> <li> <p>CRC incidence</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Attendance rates</p> </li> <li> <p>Adverse effects</p> </li> <li> <p>CRC staging</p> </li> <li> <p>Use of endoscopy work‐up.</p> </li> </ul> </p> </section> </section> </section> <section id="CD009259-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009259-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 11), MEDLINE and EMBASE (until 16 November 2012) for eligible papers. Separate searches were performed for faecal occult blood test (FOBT) and flexible sigmoidoscopy trials for each database. The reference lists of all relevant retrieved studies were searched for additional trials. In addition, we searched the reference list of the Cochrane review of CRC screening using FOBT (<a href="./references#CD009259-bbs2-0053" title="HewitsonP , GlasziouP , IrwigL , TowlerB , WatsonE . Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD001216.pub2; PUBMED: 17253456] ">Hewitson 2007</a>). </p> <p>The comprehensive search strategy was developed by the authors and the Trials Search Co‐ordinator at the Cochrane Colorectal Cancer Group, Copenhagen, Denmark, and is available in the appendix section: MEDLINE searches (<a href="./appendices#CD009259-sec-0085">Appendix 1</a>; <a href="./appendices#CD009259-sec-0086">Appendix 2</a>); EMBASE searches (<a href="./appendices#CD009259-sec-0087">Appendix 3</a>; <a href="./appendices#CD009259-sec-0088">Appendix 4</a>); CENTRAL searches <a href="./appendices#CD009259-sec-0089">Appendix 5</a>; <a href="./appendices#CD009259-sec-0090">Appendix 6</a>). The first search was performed in January 2011 and was updated November 16, 2012. </p> </section> </section> <section id="CD009259-sec-0046"> <h3 class="title" id="CD009259-sec-0046">Data collection and analysis</h3> <section id="CD009259-sec-0047"> <h4 class="title">Selection of studies</h4> <p>One investigator (OH) excluded obviously irrelevant titles from the first search. Two authors (OH and MB) independently considered the remaining abstracts and potentially relevant full‐text articles were obtained. The same authors independently considered the full‐text manuscripts according to the pre‐specified inclusion and exclusion criteria. Disagreement was resolved by consensus. </p> </section> <section id="CD009259-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>Data were extracted from the included studies into an electronic data sheet by OH and MB working independently and were finally compared. Discrepancies were addressed and solved by re‐reviewing the papers together. The abstracted data included the study citation, study design, country, methods of randomisation and allocation concealment, type of intervention, definition of positive screening test, length of follow‐up, inclusion and exclusion criteria, participants' characteristics, number of individuals randomised, number of excluded participants, participants lost to follow‐up, compliance with screening, blinding of outcome assessment, number of new cases of CRC, mortality from CRC, mortality from all causes, staging of CRC, adverse effects due to the screening procedure, use of endoscopic and radiologic work‐up after a positive screening test and funding. </p> </section> <section id="CD009259-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The methodologic quality of the included trials was assessed by two independent review authors (OH and MB) according to the Cochrane Collaboration's Risk of Bias tool(<a href="./references#CD009259-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane handbook of Systematic reviews of Intervention Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Wiley/Blackwell, 2008. ">Higgins 2008</a>). Disagreement was resolved by consensus. We included a description and assessment of the risk of bias associated with generation of the randomisation sequence, allocation concealment, blinding, incomplete outcome data, selective reporting of data and other potential threats to validity for each of the included studies. Risk of bias in the included studies was explicitly judged for each of these domains and categorized as 'low risk', 'high risk' or 'unclear' of bias, if information was insufficient to assess risk. </p> <p>If at least one of the six domains was assessed as being at 'high risk of bias' for a trial then the aggregate risk of bias for that trial was set as high. </p> </section> <section id="CD009259-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated and reported risk ratios (RR) with corresponding 95% credibility intervals (from a Bayesian network meta‐analysis model) on an intention‐to‐treat basis for all outcomes. In addition, we performed traditional pair‐wise comparisons for FOBT and flexible sigmoidoscopy trials separately for all outcomes and reported relative risk with 95% confidence intervals (CI). </p> </section> <section id="CD009259-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <section id="CD009259-sec-0052"> <h5 class="title">Cluster randomised trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice), but analysis and pooling of clustered data poses problems. Authors often fail to account for intra‐class correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD009259-bbs2-0049" title="DivineGW , BrownJT , FrazerLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;4:623‐9. ">Divine 1992</a>) whereby P values are spuriously low, CIs unduly narrow and statistical significance overestimated. This can cause type I errors (<a href="./references#CD009259-bbs2-0046" title="BlandJM , KerrySM . Statistics notes. Trials randomised in clusters. BMJ1997;300:600. ">Bland 1997</a>; <a href="./references#CD009259-bbs2-0052" title="GullifordMC , UkoumunneOC , ChinnS . Components of variance and intra class correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876‐83. ">Gulliford 1999</a>). </p> <p>Where clustering was not accounted for in the primary studies, this was specified in the footnote of the analysis to indicate the presence of a possible unit of analysis error. We contacted the first authors of studies to obtain the intra‐class correlation coefficient of their clustered data and to adjust for this by using the effective sample size method (Section 16.3.4 in <a href="./references#CD009259-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane handbook of Systematic reviews of Intervention Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Wiley/Blackwell, 2008. ">Higgins 2008</a>). We additionally performed a sensitivity analysis in which cluster randomised trials were excluded. </p> </section> </section> <section id="CD009259-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>All analyses were carried out on an intention‐to‐treat basis; that is, participants were analysed according to their allocated treatment (irrespective of whether they adhered to the screening intervention or not). For participants lost to follow‐up it was assumed that the relevant events (CRC death, death due to any reason, or CRC) did not occur. </p> </section> <section id="CD009259-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity separately for each paired comparison of two different screening strategies, on the basis of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> recommendations (I<sup>2</sup> values of 0% to 40%: might not be important; 30% to 60%: may represent moderate heterogeneity; 50% to 90%: may represent substantial heterogeneity; 75% to 100%: considerable heterogeneity) (<a href="./references#CD009259-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane handbook of Systematic reviews of Intervention Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Wiley/Blackwell, 2008. ">Higgins 2008</a>). In addition to the I<sup>2</sup> measurement we presented the χ<sup>2</sup> and its P value and considered the direction and magnitude of the treatment effects. As the χ<sup>2</sup> test in a meta‐analysis with few studies is underpowered to detect heterogeneity should it exist, a P value of 0.10 was used as the threshold of statistical significance. </p> </section> <section id="CD009259-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of the results. These biases include publication bias and selective outcome reporting bias. Funnel plots can be useful in assessing reporting biases. We intended only to produce funnel plots and apply Peters' test for asymmetry (<a href="./references#CD009259-bbs2-0062" title="PetersJL , SuttonAJ , JonesDR , AbramsKR , RushtonL . Comparison of two methods to detect publication bias in meta‐analysis. JAMA2006;295:676‐80. ">Peters 2006</a>) for outcome measures which included at least 10 studies of different sizes, as suggested by <a href="./references#CD009259-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane handbook of Systematic reviews of Intervention Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Wiley/Blackwell, 2008. ">Higgins 2008</a>. </p> </section> <section id="CD009259-sec-0056"> <h4 class="title">Data synthesis</h4> <p>The analysis was based on the method of multiple treatment meta‐analysis (MTM) as described by <a href="./references#CD009259-bbs2-0065" title="SalantiG , HigginsJP , AdesAE , IoannidisJPA . Evaluation of networks of randomized trials. Statistical Methods in Medical Research2007;17:279‐301. ">Salanti 2007</a>. We used the contrast‐based network meta‐analyses method proposed by Salanti et al (a Bayesian method based on the Markov Chain Monte Carlo simulation). All MTMs were performed using Winbugs version 1.4.3 (Imperial College and MRC, UK) utilizing random effects models. The estimates obtained by generating three chains with 10,000 initial iterations (burn in) and 50,000 iterations were used for the estimations. All results for the MTM were reported as posterior median with corresponding 95% credibility intervals (CrI). </p> <p>We only combined studies in meta‐analyses if we found that the studies were sufficiently similar to each other with regard to population, context, and method of implementation of the screening intervention. </p> <p>In addition to the estimates of effect based on the MTM analysis, we also presented results from traditional pair‐wise comparisons for FOBT and flexible sigmoidoscopy against 'no screening' separately. Results were presented as relative risk with 95% confidence interval (CI). </p> <p>We assessed the quality of the evidence as high, moderate, low or very low using the GRADE approach (<a href="./references#CD009259-bbs2-0066" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreteing results and drawing conclusions. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008. ">Schünemann 2008</a>) and have presented the results in the 'Summary of findings' table. In the absence of formal guidance regarding the application of GRADE to network meta‐analysis, we have downgraded the quality of evidence by default for indirectness where network meta‐analysis results are based solely on indirect evidence. </p> </section> <section id="CD009259-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>No subgroup analyses were planned.</p> </section> <section id="CD009259-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>MTM aggregates both direct (i.e. from the same trial) and indirect (i.e. from different trials) evidence to an aggregate estimate of effect for a comparison between two interventions. We intended to apply sensitivity analyses excluding indirect evidence in the event of using both indirect and direct evidence comparing FOBT and flexible sigmoidoscopy. As follow‐up was very different among the trials, we performed a 10‐year follow‐up sensitivity analysis. In this analysis, only the endoscopy screening trials and the FOBT trials with approximately 10 years of follow‐up were compared. </p> <p>Furthermore, we performed sensitivity analyses in which cluster randomised trials were excluded. We also performed sensitivity analyses where trials that were assessed as being at high risk of bias (the aggregate assessment across all six domains) were excluded. Finally, we decided to conduct an analysis where we excluded results from annual FOBT screening, that is we only included biennial FOBT screening, which is the most widely used approach. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009259-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009259-sec-0059"></div> <section id="CD009259-sec-0060"> <h3 class="title">Description of studies</h3> <section id="CD009259-sec-0061"> <h4 class="title">Results of the search</h4> <p>Our literature search identified 3224 titles, and abstracts were obtained for 155 of these (<a href="#CD009259-fig-0001">Figure 1</a>). Following the reading of the abstracts, 33 full‐text articles were retrieved and considered for inclusion. Ten were subsequently excluded (see <a href="./references#CD009259-sec-0111" title="">Characteristics of excluded studies</a>) leaving 22 manuscripts for inclusion in the final analyses and one trial which was identified as ongoing (<a href="./references#CD009259-bbs2-0042" title="PaimelaH , MalilaN , PalvaT , HakulinenT , VertioH , JarvinenH . Early detection of colorectal cancer with faecal occult blood test screening. The British Journal of Surgery2010;97(10):1567‐71. [PUBMED: 20603855] ">Paimela 2010</a>). After manual searching of the reference lists of the included papers, an additional nine studies were included, all addressing physical and psychological adverse effects of the screening procedures (<a href="./references#CD009259-bbs2-0015" title="LindholmE , BerglundB , KewenterJ , HaglindE . Worry associated with screening for colorectal carcinomas. Scandinavian Journal of Gastroenterology1997;32(3):238‐45. [PUBMED: 9085461] ">Lindholm 1997</a>; <a href="./references#CD009259-bbs2-0023" title="SchoenRE , WeissfeldJL , BowenNJ , SwitzerG , BaumA . Patient satisfaction with screening flexible sigmoidoscopy. Archives of Internal Medicine2000;160(12):1790‐6. [PUBMED: 10871972] ">Schoen 2000</a>; <a href="./references#CD009259-bbs2-0029" title="TaylorT , WilliamsonS , WardleJ , BorrillJ , SuttonS , AtkinW . Acceptability of flexible sigmoidoscopy screening in older adults in the United Kingdom. Journal of Medical Screening2000;7(1):38‐45. [PUBMED: 10807146] ">Taylor 2000</a>; <a href="./references#CD009259-bbs2-0006" title="HoffG , Thiis‐EvensenE , GrotmolT , SauarJ , VatnMH , MoenIE . Do undesirable effects of screening affect all‐cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983‐1996. European Journal of Cancer Prevention2001;10(2):131‐7. [PUBMED: 11330453] ">Hoff 2001</a>; <a href="./references#CD009259-bbs2-0013" title="LarsenIK , GrotmolT , BretthauerM , GondalG , Huppertz‐HaussG , HofstadB , et al. Continuous evaluation of patient satisfaction in endoscopy centres. Scandinavian Journal of Gastroenterology2002;37(7):850‐5. [PUBMED: 12190102] ">Larsen 2002</a>; <a href="./references#CD009259-bbs2-0021" title="ParkerMA , RobinsonMH , ScholefieldJH , HardcastleJD . Psychiatric morbidity and screening for colorectal cancer. Journal of Medical Screening2002;9(1):7‐10. [PUBMED: 11943790] ">Parker 2002</a>; <a href="./references#CD009259-bbs2-0020" title="MilesA , WardleJ , McCafferyK , WilliamsonS , AtkinW . The effects of colorectal cancer screening on health attitudes and practices. Cancer Epidemiology, Biomarkers &amp; Prevention2003;12(7):651‐5. [PUBMED: 12869406] ">Miles 2003</a>; <a href="./references#CD009259-bbs2-0031" title="WardleJ , WilliamsonS , SuttonS , BiranA , McCafferyK , CuzickJ , et al. Psychological impact of colorectal cancer screening. Health Psychology2003;22(1):54‐9. [PUBMED: 12558202] ">Wardle 2003</a>; <a href="./references#CD009259-bbs2-0014" title="LarsenIK , GrotmolT , AlmendingenK , HoffG . Impact of colorectal cancer screening on future lifestyle choices: a three‐year randomized controlled trial. Clinical Gastroenterology and Hepatology2007;5(4):477‐83. [PUBMED: 17363335] ">Larsen 2007</a>). In addition, we contacted the corresponding authors of the Swedish and Italian trials to obtain further information. </p> <div class="figure" id="CD009259-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD009259-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD009259-sec-0062"> <h4 class="title">Included studies</h4> <p>Nine separate trials were included in the review, but due to the multiple reports that they have generated, we report on the characteristics of 31 separate study comparisons in <a href="./references#CD009259-sec-0110" title="">Characteristics of included studies</a> and <a href="#CD009259-tbl-0002">Table 1</a>. Eleven reports from four randomised controlled trials that reported on mortality or the incidence of CRC on repeated FOBT versus no screening were identified: one Swedish (<a href="./references#CD009259-bbs2-0009" title="KewenterJ , BrevingeH , EngarasB , HaglindE , AhrenC . Results of screening, rescreening, and follow‐up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scandinavian Journal of Gastroenterology1994;29(5):468‐73. [PUBMED: 8036464] ">Kewenter 1994</a>; <a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>), one Danish (<a href="./references#CD009259-bbs2-0011" title="KronborgO , FengerC , OlsenJ , JorgensenOD , SondergaardO . Randomised study of screening for colorectal cancer with faecal‐occult‐blood test. Lancet1996;348(9040):1467‐71. [PUBMED: 8942774] ">Kronborg 1996</a>; <a href="./references#CD009259-bbs2-0008" title="JorgensenOD , KronborgO , FengerC . A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut2002;50(1):29‐32. [PUBMED: 11772963] ">Jorgensen 2002</a>; <a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>), one English (<a href="./references#CD009259-bbs2-0004" title="HardcastleJD , ChamberlainJO , RobinsonMH , MossSM , AmarSS , BalfourTW , et al. Randomised controlled trial of faecal‐occult‐blood screening for colorectal cancer. Lancet1996;348(9040):1472‐7. [PUBMED: 8942775] ">Hardcastle 1996</a>; <a href="./references#CD009259-bbs2-0025" title="ScholefieldJH , MossS , SufiF , ManghamCM , HardcastleJD . Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut2002;50(6):840‐4. [PUBMED: 12010887] ">Scholefield 2002</a>; <a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>) and one from the US (<a href="./references#CD009259-bbs2-0017" title="MandelJS , BondJH , ChurchTR , SnoverDC , BradleyGM , SchumanLM , et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England Journal of Medicine1993;328(19):1365‐71. [PUBMED: 8474513] ">Mandel 1993</a>; <a href="./references#CD009259-bbs2-0018" title="MandelJS , ChurchTR , EdererF , BondJH . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. Journal of the National Cancer Institute1999;91(5):434‐7. [PUBMED: 10070942] ">Mandel 1999</a>; <a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>). Due to the pre‐specified inclusion criteria, only the latest reports (with the longest follow‐up) were included in the main meta‐analysis. </p> <div class="table" id="CD009259-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screening</b> </p> <p><b>modality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control group (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screening group (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Men/Women (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Compliance<sup>+</sup>  (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> <p><b>(years)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Volunteers</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1975‐1992*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A:15570</p> <p>B:15587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22367/24184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A: 90</p> <p>B: 90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1981‐1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72172/78079<sup>++</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 11.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1985‐2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30966</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30967</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29714/32219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1982‐1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 15.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United Kingdom</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Volunteers</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1994‐1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112939</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57099</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83331/86707</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 11.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Volunteers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1993‐2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55‐74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77455</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76684/78216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Single: 87</p> <p>Dual: 51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality:</p> <p>median 12.1</p> <p>Incidence:</p> <p>median 11.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Volunteers</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1995‐1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17234/17168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality:</p> <p>median 11.4</p> <p>Incidence:</p> <p>median 10.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (NORCCAP)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1999‐2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41092</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13653</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%**</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality:  </p> <p>Median 6</p> <p>Incidence:</p> <p>median 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway</p> <p>(TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400/399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Characteristics of included studies. *Hiatus in screening 1982‐1986, ** Actual figures not reported, A: Annual screening, B: Biennial screening, NR: Not reported, gFOBT: guaiac faecal occult blood test. FS: Flexible Sigmoidoscopy <sup>+</sup>At least 1 round in FOBT trials, <sup>++</sup>Sum of men and women  does not equal sum of screening and control group due to difference in reporting, please see characteristics of included studies for further explanation. </p> </div> </div> <p>Flexible sigmoidoscopy versus no screening was evaluated in five randomised controlled trials: one British (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), one Italian (SCORE, Screening COlon Rectum) (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>), one from the US (PLCO, Prostate, Lung, Colorectal and Ovarian cancer screening trial) (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>) and two Norwegian trials (TPS, Telemark Polyp Study (<a href="./references#CD009259-bbs2-0005" title="HoffG , SauarJ , VatnMH , LarsenS , LangmarkF , MoenIE , et al. Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow‐up of the Telemark Polyp Study I. A prospective, controlled population study. Scandinavian Journal of Gastroenterology1996;31(10):1006‐10. [PUBMED: 8898422] ">Hoff 1996</a>; <a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>) and the Norwegian Colorectal Cancer Prevention (NORCCAP) trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>)). We did not identify any trials comparing FOBT and flexible sigmoidoscopy directly with respect to mortality from CRC. Fourteen papers reporting adverse effects in the identified screening trials were included (<a href="./references#CD009259-bbs2-0010" title="KewenterJ , BrevingeH . Endoscopic and surgical complications of work‐up in screening for colorectal cancer. Diseases of the Colon and Rectum1996;39(6):676‐80. [PUBMED: 8646956] ">Kewenter 1996</a>; <a href="./references#CD009259-bbs2-0015" title="LindholmE , BerglundB , KewenterJ , HaglindE . Worry associated with screening for colorectal carcinomas. Scandinavian Journal of Gastroenterology1997;32(3):238‐45. [PUBMED: 9085461] ">Lindholm 1997</a>; <a href="./references#CD009259-bbs2-0022" title="RobinsonMH , HardcastleJD , MossSM , AmarSS , ChamberlainJO , ArmitageNC , et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut1999;45(4):588‐92. [PUBMED: 10486370] ">Robinson 1999</a>; <a href="./references#CD009259-bbs2-0029" title="TaylorT , WilliamsonS , WardleJ , BorrillJ , SuttonS , AtkinW . Acceptability of flexible sigmoidoscopy screening in older adults in the United Kingdom. Journal of Medical Screening2000;7(1):38‐45. [PUBMED: 10807146] ">Taylor 2000</a>; <a href="./references#CD009259-bbs2-0023" title="SchoenRE , WeissfeldJL , BowenNJ , SwitzerG , BaumA . Patient satisfaction with screening flexible sigmoidoscopy. Archives of Internal Medicine2000;160(12):1790‐6. [PUBMED: 10871972] ">Schoen 2000</a>; <a href="./references#CD009259-bbs2-0006" title="HoffG , Thiis‐EvensenE , GrotmolT , SauarJ , VatnMH , MoenIE . Do undesirable effects of screening affect all‐cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983‐1996. European Journal of Cancer Prevention2001;10(2):131‐7. [PUBMED: 11330453] ">Hoff 2001</a>; <a href="./references#CD009259-bbs2-0001" title="AtkinWS , CookCF , CuzickJ , EdwardsR , NorthoverJM , WardleJ . Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet2002;359(9314):1291‐300. [PUBMED: 11965274] ">Atkin 2002</a>; <a href="./references#CD009259-bbs2-0013" title="LarsenIK , GrotmolT , BretthauerM , GondalG , Huppertz‐HaussG , HofstadB , et al. Continuous evaluation of patient satisfaction in endoscopy centres. Scandinavian Journal of Gastroenterology2002;37(7):850‐5. [PUBMED: 12190102] ">Larsen 2002</a>; <a href="./references#CD009259-bbs2-0021" title="ParkerMA , RobinsonMH , ScholefieldJH , HardcastleJD . Psychiatric morbidity and screening for colorectal cancer. Journal of Medical Screening2002;9(1):7‐10. [PUBMED: 11943790] ">Parker 2002</a>; <a href="./references#CD009259-bbs2-0027" title='SegnanN , SenoreC , AndreoniB , AsteH , BonelliL , CrostaC , et al. Baseline findings of the Italian multicenter randomized controlled trial of "once‐only sigmoidoscopy"‐‐SCORE. Journal of the National Cancer Institute2002;94(23):1763‐72. [PUBMED: 12464648] '>Segnan 2002</a>; <a href="./references#CD009259-bbs2-0003" title="GondalG , GrotmolT , HofstadB , BretthauerM , EideTJ , HoffG . The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work‐up in age groups 50‐64 years. Scandinavian Journal of Gastroenterology2003;38(6):635‐42. [PUBMED: 12825872] ">Gondal 2003</a>; <a href="./references#CD009259-bbs2-0020" title="MilesA , WardleJ , McCafferyK , WilliamsonS , AtkinW . The effects of colorectal cancer screening on health attitudes and practices. Cancer Epidemiology, Biomarkers &amp; Prevention2003;12(7):651‐5. [PUBMED: 12869406] ">Miles 2003</a>; <a href="./references#CD009259-bbs2-0031" title="WardleJ , WilliamsonS , SuttonS , BiranA , McCafferyK , CuzickJ , et al. Psychological impact of colorectal cancer screening. Health Psychology2003;22(1):54‐9. [PUBMED: 12558202] ">Wardle 2003</a>; <a href="./references#CD009259-bbs2-0014" title="LarsenIK , GrotmolT , AlmendingenK , HoffG . Impact of colorectal cancer screening on future lifestyle choices: a three‐year randomized controlled trial. Clinical Gastroenterology and Hepatology2007;5(4):477‐83. [PUBMED: 17363335] ">Larsen 2007</a>). </p> <section id="CD009259-sec-0063"> <h5 class="title">Faecal occult blood trials</h5> <p>Altogether, the four FOBT trials included 172,734 individuals in the screening groups and 156,908 in the control groups (<a href="./references#CD009259-bbs2-0018" title="MandelJS , ChurchTR , EdererF , BondJH . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. Journal of the National Cancer Institute1999;91(5):434‐7. [PUBMED: 10070942] ">Mandel 1999</a>; <a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>; <a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>; <a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>). Individuals were aged 45 to 80 years. All participants were randomised either on an individual basis or by household. The US study (<a href="./references#CD009259-bbs2-0018" title="MandelJS , ChurchTR , EdererF , BondJH . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. Journal of the National Cancer Institute1999;91(5):434‐7. [PUBMED: 10070942] ">Mandel 1999</a>) included volunteers to the study, while the other three invited participants from public registries. All FOBT trials used a guaiac‐based test. The test was rehydrated in the majority of cases in the US (<a href="./references#CD009259-bbs2-0018" title="MandelJS , ChurchTR , EdererF , BondJH . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. Journal of the National Cancer Institute1999;91(5):434‐7. [PUBMED: 10070942] ">Mandel 1999</a>) and Swedish (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>) trials, but not in Denmark (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>) and England (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>). Dietary restrictions were applied in all trials except the Swedish trial (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>). In the US and Danish trials (<a href="./references#CD009259-bbs2-0018" title="MandelJS , ChurchTR , EdererF , BondJH . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. Journal of the National Cancer Institute1999;91(5):434‐7. [PUBMED: 10070942] ">Mandel 1999</a>; <a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>), all participants with at least one positive test slide out of six were referred for diagnostic work‐up. In the English trial (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>) and among 44% of participants in the Swedish trial (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>) an initial positive FOBT was investigated through a second FOBT, and those who tested positive the second time were referred for a diagnostic work‐up. Work‐up included full colonoscopy, except in the Swedish trial (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>) where a flexible sigmoidoscopy and double contrast barium enema was applied. Biennial screening was offered in the Danish (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>) and English (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>) trials throughout the study period. In the US study (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>), participants in the intervention group were randomised 1:1 to biennial or annual screening. There was a three to five year hiatus in the screening period in this trial. Originally the trial ended in 1982, but due to lower than expected CRC mortality in the control group, screening was re‐instituted in 1986 and this second phase ended in 1992. In the Swedish trial (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>), three cohorts of participants were included at different time points. All these cohorts had their own screening schedule. Two cohorts had re‐screening 21 to 24 months after the first FOBT. These cohorts were included in the biennial screening analyses. The last cohort had two re‐screenings with an 18 months interval after the initial screen, and this cohort was only included in the analysis considering all FOBT trials. The number of offered screening rounds varied between the FOBT studies. Nine rounds were offered in the Danish trial (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>), but only participants in the preceding round were invited for further screening. A no re‐invitation procedure was initially also applied in the English trial (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>), but was abandoned half‐way through the study in an effort to increase compliance with screening, resulting in an offer to be screened for three to six rounds. In the Swedish trial (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>), screening was offered two to three times in the different cohorts. The annual screening group was invited for 11 screening rounds in the US trial (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>), and six rounds were offered to the biennial screening group. Follow‐up was reported after 18 and 17 years in the US (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>) and Danish (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>) FOBT trials, and after a median of 19.5 years in the English trial (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>) and 15.5 years in the Swedish trial (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>). Participants with known prior CRC were excluded in all trials. </p> </section> <section id="CD009259-sec-0064"> <h5 class="title">Flexible sigmoidoscopy screening trials</h5> <p>In the five identified trials, 165,733 individuals were randomised to flexible sigmoidoscopy and 249,011 individuals comprised the control groups who received care as usual. Four trials applied a once‐only screening intervention (one screening flexible sigmoidoscopy only for each participant) (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>; <a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>; <a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>; <a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>), while the US trial offered the screening group a second flexible sigmoidoscopy three to five years after the first (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>). Eligible individuals were aged 50 to 74 years. Time to follow‐up for the primary outcome was different between the trials. Median follow‐up for CRC mortality was six years in the largest Norwegian trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>), and 11.2, 11.4 and 11.9 years in the British (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) and US (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>) trials, respectively. The smaller Norwegian trial (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>) reported mortality from CRC after 13 years of follow‐up. All trials referred screening‐positive individuals to colonoscopy work‐up, but the definition of a positive test varied between the studies. In the US trial (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>), finding of any lesion or mass during screening qualified for colonoscopy referral to the individual's primary care physician for follow‐up. In the British trial (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), a positive test was defined as the finding of any polyp 10 mm in diameter or larger, advanced adenoma (tubulovillous or villous histology, severe dysplasia or three or more adenomas) irrespective of size, more than 20 hyperplastic polyps proximal to the rectum, or invasive cancer. The Italian trial (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) applied the same definition as the British trial, with the exception that individuals with any polyp larger than 5 mm in diameter were also referred to colonoscopy. The large Norwegian trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>) biopsied all polyps at the initial screen and referred all individuals with histologically verified adenomas for work‐up, irrespective of size, and all individuals who harboured a polyp 10 mm in diameter or larger (irrespective of histology). In addition, half of the individuals in the screening group were randomly allocated to provide a FIT as well. Individuals with a positive FIT, irrespective of the result of the screening flexible sigmoidoscopy, were offered work‐up colonoscopy. In the small Norwegian study, all individuals with any polyp were offered colonoscopy (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>). </p> </section> </section> <section id="CD009259-sec-0065"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD009259-sec-0111" title="">Characteristics of excluded studies</a>. Ten trials were excluded from the review: five trials assessed the effect of FOBT on one occasion only (<a href="./references#CD009259-bbs2-0032" title="BerryDP , ClarkeP , HardcastleJD , VellacottKD . Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. The British Journal of Surgery1997;84(9):1274‐6. [PUBMED: 9313712] ">Berry 1997</a>; <a href="./references#CD009259-bbs2-0033" title="BrevingeH , LindholmE , BuntzenS , KewenterJ . Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55‐56 years' old population. International Journal of Colorectal Disease1997;12(5):291‐5. [PUBMED: 9401844] ">Brevinge 1997</a>; <a href="./references#CD009259-bbs2-0037" title="RasmussenM , KronborgO , FengerC , JorgensenOD . Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult‐II in screening for colorectal cancer. A randomized study. Scandinavian Journal of Gastroenterology1999;34(1):73‐8. [PUBMED: 10048736] ">Rasmussen 1999</a>; <a href="./references#CD009259-bbs2-0036" title="LiS , NieZ , LiN , LiJ , ZhangP , YangZ , et al. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study. Chinese Medical Journal2003;116(2):200‐2. [PUBMED: 12775229] ">Li 2003</a>; <a href="./references#CD009259-bbs2-0041" title="ZhengS , ChenK , LiuX , MaX , YuH , ChenK , et al. Cluster randomization trial of sequence mass screening for colorectal cancer. Diseases of the Colon and Rectum2003;46(1):51‐8. [PUBMED: 12544522] ">Zheng 2003</a>); three trials were non‐randomised studies (<a href="./references#CD009259-bbs2-0040" title="WinawerSJ , FlehingerBJ , SchottenfeldD , MillerDG . Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. Journal of the National Cancer Institute1993;85(16):1311‐8. [PUBMED: 8340943] ">Winawer 1993</a>; <a href="./references#CD009259-bbs2-0035" title="FaivreJ , DancourtV , LejeuneC , TaziMA , LamourJ , GerardD , et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology2004;126(7):1674‐80. [PUBMED: 15188160] ">Faivre 2004</a>; <a href="./references#CD009259-bbs2-0034" title="DenisB , GendreI , AmanF , RibsteinF , MaurinP , PerrinP . Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac‐based faecal occult blood testing: a French population‐based controlled study (Wintzenheim trial). European Journal of Cancer2009;45(18):3282‐90. [PUBMED: 19665368] ">Denis 2009</a>); one had a quasi‐randomised design and used a rigid endoscope (<a href="./references#CD009259-bbs2-0038" title="SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. [PUBMED: 3367172] ">Selby 1988</a>); and one trial did not report the predefined primary outcome (<a href="./references#CD009259-bbs2-0039" title="Thiis‐EvensenE , HoffGS , SauarJ , MajakBM , VatnMH . The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13‐year follow‐up. The American Journal of Gastroenterology2001;96(6):1901‐7. [PUBMED: 11419846] ">Thiis‐Evensen 2001</a>). </p> <section id="CD009259-sec-0066"> <h5 class="title">Ongoing studies</h5> <p>See <a href="./references#CD009259-sec-0112" title="">Characteristics of ongoing studies</a>. The search identified one ongoing trial: in Finland, a national screening program was launched as a randomised controlled trial in selected regions in 2004 (<a href="./references#CD009259-bbs2-0042" title="PaimelaH , MalilaN , PalvaT , HakulinenT , VertioH , JarvinenH . Early detection of colorectal cancer with faecal occult blood test screening. The British Journal of Surgery2010;97(10):1567‐71. [PUBMED: 20603855] ">Paimela 2010</a>). Between 2004 and 2006, people aged 60 to 64 years who were living in these areas were randomised 1:1 to screening with guaiac‐based FOBT biennially or no screening; 52,998 people were included in the intervention group and 53,002 in the control group. The primary outcome is mortality from CRC and follow‐up analyses are planned in 2014. </p> </section> </section> </section> <section id="CD009259-sec-0067"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD009259-sec-0110" title="">Characteristics of included studies</a> and <a href="#CD009259-fig-0002">Figure 2</a>. In general, the risk of bias was judged as low. In the Norwegian Telemark Polyp Study (TPS) (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>), risk of bias was rated as 'high' due to an inadequate randomisation procedure; in the intervention group, participants were drawn from the population registry among those born in January and February, while controls were randomised irrespective of month of birth. This introduced a potential selection bias. The TPS investigators indeed discovered a month‐of‐birth all‐cause mortality difference, which confirms that a selection bias actually may have occurred (<a href="./references#CD009259-bbs2-0005" title="HoffG , SauarJ , VatnMH , LarsenS , LangmarkF , MoenIE , et al. Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow‐up of the Telemark Polyp Study I. A prospective, controlled population study. Scandinavian Journal of Gastroenterology1996;31(10):1006‐10. [PUBMED: 8898422] ">Hoff 1996</a>). The remaining studies used adequate randomisation procedures. We did not detect any high risk of bias with respect to allocation concealment or blinding. </p> <div class="figure" id="CD009259-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009259-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>Blinding of participants was obviously not possible due to the nature of the interventions. Blinded verification of cause of death by independent experts who scrutinized the death certificates supplied with clinical information, when available, were performed in all trials except the two Norwegian trials. </p> <p>All trials reported analyses by intention to treat. Loss to follow‐up rates were 0.1% to 6.2%. </p> <p>In three of the six regions in the Italian flexible sigmoidoscopy trial (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>), participants were randomised on an individual or household basis. Cluster randomisation was applied in the other three regions with the general practitioner as the cluster unit. We contacted the principal investigator of the Italian trial (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) to obtain the intra‐cluster correlation coefficient, but this was not calculated. </p> <p>The Danish (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>), Swedish (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>) and English (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>) FOBT trials and the two Norwegian flexible sigmoidoscopy trials (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>; <a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>) had a population‐based design in which all, or a random sample of, age‐eligible individuals were randomised to the intervention or the control group. In the US (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>), British (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>) and Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) flexible sigmoidoscopy screening trials and in the US FOBT trial (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>), individuals were recruited to participate in the trials from volunteers. </p> </section> <section id="CD009259-sec-0068"> <h3 class="title" id="CD009259-sec-0068">Effects of interventions</h3> <p>See: <a href="./full#CD009259-tbl-0001"><b>Summary of findings for the main comparison</b> Screening for colorectal cancer with flexible sigmoidoscopy or faecal occult blood test</a> </p> <section id="CD009259-sec-0069"> <h4 class="title">Colorectal cancer (CRC) mortality</h4> <p>See <a href="./references#CD009259-fig-0003" title="">Analysis 1.1</a>; <a href="./full#CD009259-tbl-0001">summary of findings Table for the main comparison</a>; Summary of findings table 2. In the pairwise meta‐analysis (random‐effects model), the relative risk of mortality due to CRC was 0.86 (95% CI 0.80 to 0.92; four studies, N = 329,642) for FOBT compared to no screening (GRADE: high). The relative risk of CRC mortality was 0.72 (95% CI 0.65 to 0.79, five studies, N = 414,754) for flexible sigmoidoscopy compared to no screening (GRADE: high). There were no signs of significant heterogeneity between the trials (I<sup>2</sup> = 18% and 0% for the FOBT and flexible sigmoidoscopy comparisons, respectively). The risk of CRC mortality was reduced from 8 per 1000 across the control groups to 7 (95% CI 6 to 7) per 1000 with FOBT, and 6 (95% CI 5 to 6) per 1000 with sigmoidocopy. </p> <p>In the multiple treatment meta‐analysis (MTM), the relative risk (with 95% credibility interval (CrI)) of CRC mortality for flexible sigmoidoscopy compared to FOBT was 0.85 (95% CrI 0.72 to 1.01) (GRADE: low). </p> <p>In the sensitivity analyses, we first excluded the trial with high risk of selection bias (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>). This did not alter our results. As the intra‐cluster correlation coefficient was not reported in the Italian flexible sigmoidoscopy trial (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>), this study was excluded in a sensitivity analysis as pre‐specified in our protocol, without altering the results. When we limited the analysis and compared flexible sigmoidoscopy screening to biennial screening for faecal occult blood only (that is annual FOBT screening was excluded), the relative risk of dying due to CRC was 0.81 for flexible sigmoidoscopy screening compared to screening with FOBT (95% Crl 0.70 to 0.96) (GRADE: moderate). </p> <p>In the US FOBT trial (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>), 28% to 38% of participants had a colonoscopy during the trial compared to 4.4% to 8.8% in the other FOBT trials. When we excluded this trial from the MTM analysis asa post hoc sensitivity analysis, the relative risk for CRC mortality was 0.83 (95% Crl 0.70 to 0.99) when screening with flexible sigmoidoscopy was compared to FOBT. </p> <p>Length of follow‐up varied significantly between studies, ranging from a median of six years in the NORCCAP trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>) to 19.5 years of follow‐up in the English FOBT trial (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>). We therefore performed a sensitivity analysis (MTM) in which trials with approximately 10 years of follow‐up were included; the Norwegian NORCCAP trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>) was excluded due to the short follow‐up (six years) leaving the British, Italian, US and Norwegian TPS trials eligible for analysis, with follow‐up of approximately 11 to 13 years (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>; <a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>; <a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>; <a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>). All FOBT trials were included, but we used the reports with follow‐up as close to 10 years as possible, which were identical to the first reports of the CRC mortality and incidence of the trials (<a href="./references#CD009259-bbs2-0017" title="MandelJS , BondJH , ChurchTR , SnoverDC , BradleyGM , SchumanLM , et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England Journal of Medicine1993;328(19):1365‐71. [PUBMED: 8474513] ">Mandel 1993</a>; <a href="./references#CD009259-bbs2-0004" title="HardcastleJD , ChamberlainJO , RobinsonMH , MossSM , AmarSS , BalfourTW , et al. Randomised controlled trial of faecal‐occult‐blood screening for colorectal cancer. Lancet1996;348(9040):1472‐7. [PUBMED: 8942775] ">Hardcastle 1996</a>; <a href="./references#CD009259-bbs2-0011" title="KronborgO , FengerC , OlsenJ , JorgensenOD , SondergaardO . Randomised study of screening for colorectal cancer with faecal‐occult‐blood test. Lancet1996;348(9040):1467‐71. [PUBMED: 8942774] ">Kronborg 1996</a>; <a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>). The relative risk for death due to CRC was 0.87 (95% Crl 0.73 to 1.05) for flexible sigmoidoscopy compared to FOBT. </p> </section> <section id="CD009259-sec-0070"> <h4 class="title">Colorectal cancer incidence and staging</h4> <p>See <a href="./references#CD009259-fig-0004" title="">Analysis 1.2</a>; <a href="./full#CD009259-tbl-0001">summary of findings Table for the main comparison</a>; Summary of findings table 2. The incidence of CRC was reduced by 18% in the flexible sigmoidoscopy trials, relative risk of 0.82 (95% CI 0.73 to 0.90; five studies, N = 414,744) in the random‐effects model, but with substantial heterogeneity between the included studies (I<sup>2</sup> = 60%, P = 0.04, GRADE: moderate). The heterogeneity was 0% when the two Norwegian trials were removed from the analysis (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>; <a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>). When FOBT was compared to no screening, the relative risk for CRC was 0.95 (95% CI 0.88 to 1.02). There was considerable heterogeneity between the trials (I<sup>2</sup> = 64%, P = 0.04, GRADE: moderate). The risk of CRC incidence was 20 per 1000 across the control groups. Corresponding estimates of CRC incidence were 19 per 1000 with FOBT (95% CI 18 to 20), and 16 per 1000 (95% CI 15 to 18) with flexible sigmoidocopy. </p> <p>In the MTM analysis, the relative risk of CRC incidence with flexible sigmoidoscopy compared to FOBT was 0.85 (95% Crl 0.72 to 1.02) (GRADE: low). </p> <p>In the sensitivity analyses, the trial with high risk of bias (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>), the partly cluster randomised trial (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) and the short follow‐up Norwegian trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>) were excluded, and results in the MTM analyses were unchanged from the main analysis. When we excluded the US FOBT trial (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>) trial, due to the very high colonoscopy rate in this study, the risk of being diagnosed with CRC was 18% lower if screening with flexible sigmoidoscopy was offered compared to FOBT (relative risk (RR) 0.82; 95% Crl 0.71 to 0.96). In the 10‐year analysis, the CRC incidence was reduced by 21% when flexible sigmoidoscopy screening was compared to FOBT (RR 0.79; 95% Crl 0.70 to 0.90). In the analysis which only included biennial FOBT screening compared to flexible sigmoidoscopy, the results were similar to those in our main analysis (RR 0.82; 95% Crl 0.67 to 1.01). </p> <p>The effect of screening on colorectal cancer staging was reported in all but the British trial. All showed a favourable shift towards less advanced tumours in the screening group, see <a href="#CD009259-tbl-0003">Table 2</a>. </p> <div class="table" id="CD009259-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Histologic classification of colorectal cancers in the screening and control groups</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Screening group</b> </p> <p><b>Duke classification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Control group</b> </p> <p><b>Duke classification</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>A</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>B</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>C</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>D</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>A</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>B</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>C</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>D</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>FOBT trials</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States</p> <p>(annual screening)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107/354 (30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101/354 (29%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80/354 </p> <p>(23%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33/354</p> <p>(9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88/394</p> <p>(22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120/394 (30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82/394</p> <p>(21 %)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65/394</p> <p>(17%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States</p> <p>(biennial screening)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98/368</p> <p>(27%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95/368</p> <p>(26%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100/368 (27%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41/368</p> <p>(11%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88/394</p> <p>(22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120/394 (30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82/394</p> <p>(21%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65/394</p> <p>(17%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181/893 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286/893 (32%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>215/893 (24%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>192/893 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95/856</p> <p>(11%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>285/856 (33%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264/856 (31%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>179/856 (21%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105/481 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164/481 (34%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90/481</p> <p>(19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98/481</p> <p>(20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54/483</p> <p>(11%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177/483 (37%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111/483 (23%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114/483 (24%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124/721 (17%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>261/721 (36%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184/721 (26%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152/721 (21%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112/754 (15%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>260/721 (35%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>221/754 (29%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>161/754 (21%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>Flexible sigmoidoscopy trials</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United Kingdom           </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>NR </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>574/955</p> <p>(60%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>381/955</p> <p>(40%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>716/1253</p> <p>(57%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>537/1253</p> <p>(43%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy*</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>139/251</p> <p>(55%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>112/251</p> <p>(45%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>154/306</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>152/306</p> <p>(50%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway<sup>+</sup> (NORCCAP) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>33/123</p> <p>(27%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>78/123</p> <p>(63%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>62/362</p> <p>(17%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>262/362</p> <p>(72%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norway (TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/2</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/2</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/10</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/10</p> <p>(30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/10</p> <p>(20%)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Stages of colorectal cancers diagnosed in the screening and control groups. *Cancers classified according to the Union for International Cancer Control as non‐advanced (Stage I and II) or advanced (Stage III and IV). Non‐advanced cancers equals Duke A and B. Advanced cancers equals Duke C and D. <sup>+</sup>The Norwegian NORCCAP trial classified cancers according to a modified Duke classification system. Duke A and B cancers were classified as “localized”, but Duke B cancers infiltrating neighbouring organs without distant metastasis were classified as “advanced”. NR: Not reported. </p> </div> </div> </section> <section id="CD009259-sec-0071"> <h4 class="title">All‐cause mortality</h4> <p>See <a href="./references#CD009259-fig-0005" title="">Analysis 1.3</a>; <a href="./full#CD009259-tbl-0001">summary of findings Table for the main comparison</a>; Summary of findings table 2. Mortality due to death from all causes was specifically reported for all trials but one of the Norwegian trials (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>). The RR of death from all causes in the screening group was 0.98 (95% CI 0.95 to 1.01) compared to the control group in the flexible sigmoidoscopy trials, with moderate heterogeneity between the included studies (I<sup>2</sup> = 45%, P = 0.14, GRADE: high). Heterogeneity was 0% when the high risk of bias study from Norway was removed from the analysis (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>). For FOBT, the RR was 1.00 (95% CI 0.99 to 1.01) with no heterogeneity between trials (I<sup>2</sup> = 0%, GRADE: high). All‐cause mortality was 254 per 1000 in the control groups. The corresponding risk of all‐cause mortality was 254 (95% CI 251 to 257) per 1000 in the FOBT groups and 249 (95% CI 241 to 257) per 1000 in the sigmoidoscopy groups. </p> <p>MTM revealed a RR of 0.98 (95% Crls 0.95 to 1.00) for flexible sigmoidoscopy compared to FOBT (GRADE: moderate). Further sensitivity analyses, excluding studies with high risk of bias and studies with cluster design, did not change the results. </p> </section> <section id="CD009259-sec-0072"> <h4 class="title">Attendance</h4> <p>See <a href="#CD009259-tbl-0002">Table 1</a>. Attendance rates were reported in all the included trials, but it was not possible to perform an indirect comparison due to different recruitment methods and reporting. At least one screening test was completed by 59% to 70% of participants in the population‐based FOBT trials (<a href="./references#CD009259-bbs2-0025" title="ScholefieldJH , MossS , SufiF , ManghamCM , HardcastleJD . Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut2002;50(6):840‐4. [PUBMED: 12010887] ">Scholefield 2002</a>; <a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>; <a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>), see <a href="#CD009259-tbl-0002">Table 1</a>. In the US trial (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>), which recruited participants among screening volunteers, 90% of participants in both the annual and biennial screening groups completed at least one screening round. Attendance rates in the two population‐based flexible sigmoidoscopy trials were 81% in the small Norwegian trial (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>) and 65% in the larger trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>). The British (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) and US (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>) sigmoidoscopy screening trials recruited participants from among those who had reported an interest in screening. Seventy‐one per cent of those invited attended screening in the UK (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), 58% in Italy (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) and 87% in the US (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>). In the UK trial (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), 194,726 of 368,142 (53%) eligible individuals responded with interest in screening, and 43,010 of 234,569 (18%) replied with 'certain' or 'probable' interest in screening in Italy (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>). Thus, on the population level, attendance rates were 38% (0.71 x 0.53) and 10% (0.58 x 0.18) in the UK (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>) and Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) trials, respectively. In the US, the response to direct mailing varied between 0.3% and 3.4% for the 10 screening centres (<a href="./references#CD009259-bbs2-0069" title="SimpsonNK , JohnsonCC , OgdenSL , GamitoE , TrockyN , McGuireC , et al. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Controlled Clinical Trials2000;21(6 Suppl):356S‐78S. [PUBMED: 11189688] ">Simpson 2000</a>). </p> </section> <section id="CD009259-sec-0073"> <h4 class="title">Adverse effects of screening</h4> <p>See <a href="#CD009259-tbl-0004">Table 3</a>. Physical adverse effects of the screening procedure and colonoscopy work‐up were reported in all the flexible sigmoidoscopy trials, but only partly in the US trial (PLCO) (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>). There was incomplete reporting of deaths related to the screening intervention or work‐up colonoscopy and surgery. In the FOBT studies, physical adverse effects were due to colonoscopy work‐up and surgical procedures after a positive screening test; they were specifically stated for all the trials except for the Danish trial (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>), and only partly in the US trial (<a href="./references#CD009259-bbs2-0017" title="MandelJS , BondJH , ChurchTR , SnoverDC , BradleyGM , SchumanLM , et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England Journal of Medicine1993;328(19):1365‐71. [PUBMED: 8474513] ">Mandel 1993</a>). A major complication (for example bleeding, perforation or death within 30 days of screening, follow‐up colonoscopy or surgery) occurred in 0.03% and 0.08% of participants in the FOBT and flexible sigmoidoscopy trials, respectively. </p> <div class="table" id="CD009259-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Physical complications to screening</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Flexible sigmoidoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Colonoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bleeding<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Perforation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death&lt;30days of procedure<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death &lt;30 days</b> </p> <p><b>of surgery</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major complications<sup>3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Miscellaneous</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States (gFOBT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>United States</p> <p>(FS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England (gFOBT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 <sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1<sup>5</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Sweden (gFOBT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> 14<sup>15</sup> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Norway (FS, NORCCAP)<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2524</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>United Kingdom (FS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40332<sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12<sup>9</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 <sup>10</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 <sup>11</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3<sup>12</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13<sup>13</sup> </p> <p>172<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 <sup>14</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 7<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy (FS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9911</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>775</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Norway (FS, TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TOTAL</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>172871</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>4</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>3</b> </p> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> <b>376</b> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>37560</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>27</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5</b> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup> Those admitted to hospital due to bleeding </p> <p><sup>2</sup> Death within 30 days of endoscopic screening or work‐up </p> <p><sup>3</sup> Bleeding, perforation and death excluded </p> <p><sup>4</sup> Myocardial infarction, 1 anastomotic leak, 2 pulmonary embolus, 1 carcinomatosis </p> <p><sup>5</sup> Snare entrapment </p> <p><sup>6</sup> Includes individuals aged 50‐64 years </p> <p><sup>7</sup> Minor events not requiring hospitalisation </p> <p><sup>8</sup> 342 individuals had a baseline colonoscopy screening procedure due to strong family history of CRC and is included in the colonoscopy figures </p> <p><sup>9</sup>  Includes 3 individuals with glutaraldehyde colitis </p> <p><sup>10</sup> 3 myocardial infarction, 1 cardiomyopathy, 1 intracerebral haemorrhage, 1 lung cancer </p> <p><sup>11</sup> 2 cardiovascular, 1 respiratory, 1 septicaemia </p> <p><sup>12</sup> 2 myocardial infarction, 1 pulmonary embolus </p> <p><sup>13</sup> 5 cases of definite glutaraldehyde colitis and 8 probable cases </p> <p><sup>14</sup> Myocardial infarction </p> <p><sup>15</sup> 14 patients who had a laparotomy had complications which prolonged their hospital stay </p> <p>FS: Flexible sigmoidoscopy. gFOBT: Faecal occult blood test. NORCCAP: Norwegian colorectal cancer prevention trial. TPS: Telemark polyp study </p> </div> </div> <p>Psychological effects of screening were addressed in the Italian (<a href="./references#CD009259-bbs2-0027" title='SegnanN , SenoreC , AndreoniB , AsteH , BonelliL , CrostaC , et al. Baseline findings of the Italian multicenter randomized controlled trial of "once‐only sigmoidoscopy"‐‐SCORE. Journal of the National Cancer Institute2002;94(23):1763‐72. [PUBMED: 12464648] '>Segnan 2002</a>), British (<a href="./references#CD009259-bbs2-0029" title="TaylorT , WilliamsonS , WardleJ , BorrillJ , SuttonS , AtkinW . Acceptability of flexible sigmoidoscopy screening in older adults in the United Kingdom. Journal of Medical Screening2000;7(1):38‐45. [PUBMED: 10807146] ">Taylor 2000</a>; <a href="./references#CD009259-bbs2-0020" title="MilesA , WardleJ , McCafferyK , WilliamsonS , AtkinW . The effects of colorectal cancer screening on health attitudes and practices. Cancer Epidemiology, Biomarkers &amp; Prevention2003;12(7):651‐5. [PUBMED: 12869406] ">Miles 2003</a>; <a href="./references#CD009259-bbs2-0031" title="WardleJ , WilliamsonS , SuttonS , BiranA , McCafferyK , CuzickJ , et al. Psychological impact of colorectal cancer screening. Health Psychology2003;22(1):54‐9. [PUBMED: 12558202] ">Wardle 2003</a>), two Norwegian (<a href="./references#CD009259-bbs2-0006" title="HoffG , Thiis‐EvensenE , GrotmolT , SauarJ , VatnMH , MoenIE . Do undesirable effects of screening affect all‐cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983‐1996. European Journal of Cancer Prevention2001;10(2):131‐7. [PUBMED: 11330453] ">Hoff 2001</a>; <a href="./references#CD009259-bbs2-0013" title="LarsenIK , GrotmolT , BretthauerM , GondalG , Huppertz‐HaussG , HofstadB , et al. Continuous evaluation of patient satisfaction in endoscopy centres. Scandinavian Journal of Gastroenterology2002;37(7):850‐5. [PUBMED: 12190102] ">Larsen 2002</a>; <a href="./references#CD009259-bbs2-0014" title="LarsenIK , GrotmolT , AlmendingenK , HoffG . Impact of colorectal cancer screening on future lifestyle choices: a three‐year randomized controlled trial. Clinical Gastroenterology and Hepatology2007;5(4):477‐83. [PUBMED: 17363335] ">Larsen 2007</a>), Swedish (<a href="./references#CD009259-bbs2-0015" title="LindholmE , BerglundB , KewenterJ , HaglindE . Worry associated with screening for colorectal carcinomas. Scandinavian Journal of Gastroenterology1997;32(3):238‐45. [PUBMED: 9085461] ">Lindholm 1997</a>), US PLCO (<a href="./references#CD009259-bbs2-0023" title="SchoenRE , WeissfeldJL , BowenNJ , SwitzerG , BaumA . Patient satisfaction with screening flexible sigmoidoscopy. Archives of Internal Medicine2000;160(12):1790‐6. [PUBMED: 10871972] ">Schoen 2000</a>) trials and the English FOBT trial (<a href="./references#CD009259-bbs2-0021" title="ParkerMA , RobinsonMH , ScholefieldJH , HardcastleJD . Psychiatric morbidity and screening for colorectal cancer. Journal of Medical Screening2002;9(1):7‐10. [PUBMED: 11943790] ">Parker 2002</a>). Acceptance among screened persons was very high. Worry associated with the invitation or positive screening results, if present, was generally of short duration. Short‐term effects on lifestyle and health attitudes were addressed in two reports from the British study (<a href="./references#CD009259-bbs2-0020" title="MilesA , WardleJ , McCafferyK , WilliamsonS , AtkinW . The effects of colorectal cancer screening on health attitudes and practices. Cancer Epidemiology, Biomarkers &amp; Prevention2003;12(7):651‐5. [PUBMED: 12869406] ">Miles 2003</a>; <a href="./references#CD009259-bbs2-0031" title="WardleJ , WilliamsonS , SuttonS , BiranA , McCafferyK , CuzickJ , et al. Psychological impact of colorectal cancer screening. Health Psychology2003;22(1):54‐9. [PUBMED: 12558202] ">Wardle 2003</a>), and no negative effects were detected. Adverse effects on lifestyle were evaluated prospectively in a randomised controlled study within the NORCCAP trial (<a href="./references#CD009259-bbs2-0014" title="LarsenIK , GrotmolT , AlmendingenK , HoffG . Impact of colorectal cancer screening on future lifestyle choices: a three‐year randomized controlled trial. Clinical Gastroenterology and Hepatology2007;5(4):477‐83. [PUBMED: 17363335] ">Larsen 2007</a>). Three years after screening, attenders were more likely to gain weight and were less likely to stop smoking, engage in physical activity and eat fruit and vegetables compared to a randomly chosen sample from the control group. All these comparisons reached statistical significance. </p> </section> <section id="CD009259-sec-0074"> <h4 class="title">Use of colonoscopy work‐up</h4> <p>Due to disparities in the definition of a positive screening test, referral for colonoscopy varied accordingly. In the flexible sigmoidoscopy screening trials, referral rates for colonoscopy among screened persons were: 5.2% (2131/40,674), 8.4% (832/9911), 16.5% (17,672/107,236), 23% (2034/8846, combined FOBT and flexible sigmoidoscopy) and 34.6% (112/324) in the British (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>), US (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>), NORCCAP (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>) and TPS (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>) trials, respectively. The US FOBT trial referred 28% of participants in the biennial screening group and 38% in the annual screening group for colonoscopy (<a href="./references#CD009259-bbs2-0017" title="MandelJS , BondJH , ChurchTR , SnoverDC , BradleyGM , SchumanLM , et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England Journal of Medicine1993;328(19):1365‐71. [PUBMED: 8474513] ">Mandel 1993</a>). Among attenders, screen‐positive rates requiring work‐up were: 8.8% (2108/23,916), 4.4% (1977/44,838) and 8.5% (1766/20,672) in the Swedish (<a href="./references#CD009259-bbs2-0010" title="KewenterJ , BrevingeH . Endoscopic and surgical complications of work‐up in screening for colorectal cancer. Diseases of the Colon and Rectum1996;39(6):676‐80. [PUBMED: 8646956] ">Kewenter 1996</a>), English (<a href="./references#CD009259-bbs2-0004" title="HardcastleJD , ChamberlainJO , RobinsonMH , MossSM , AmarSS , BalfourTW , et al. Randomised controlled trial of faecal‐occult‐blood screening for colorectal cancer. Lancet1996;348(9040):1472‐7. [PUBMED: 8942775] ">Hardcastle 1996</a>) and Danish (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>) FOBT trials, respectively. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009259-sec-0075" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009259-sec-0075"></div> <section id="CD009259-sec-0076"> <h3 class="title" id="CD009259-sec-0076">Summary of main results</h3> <p>There was high quality evidence from the pairwise meta‐analysis that the risk of death from colorectal cancer (CRC) was reduced when faecal guaiac‐based occult blood testing (14% reduction; 95% CI 8% to 20%) or flexible sigmoidoscopy (28% reduction; 95% CI 21% to 35%) were compared to no screening. The analyses were robust without heterogeneity between flexible sigmoidoscopy screening trials, and modest heterogeneity (I<sup>2</sup> = 18%, P = 0.3) between the results of thethe FOBT trials. </p> <p>When we compared flexible sigmoidoscopy with faecal occult blood testing (FOBT) in the multiple‐treatment meta‐analysis (MTM), the estimated effect was a 15% reduction (95% CrI 1% increase to 28% reduction) in CRC mortality when screening with flexible sigmoidoscopy was compared to annual or biennial FOBT. </p> <p>In the MTM analysis, a 15% reduced incidence of cancer in colorectum was observed when screening with flexible sigmoidoscopy was compared to FOBT, but the credibility interval (CrI) crossed the value one, indicating that a difference between the screening tools might exist, but no difference cannot be ruled out. In addition, we rated this as low quality evidence, which means that we have little confidence in the effect estimate. The incidence of CRC was reduced by 18% in the flexible sigmoidoscopy trials (95% CI 26% to 10%). A reduction in the incidence of CRC by FOBT screening could not be established nor ruled out with a 5% reduction (95% CI 2% increase to 12% reduction). </p> <p>With regard to all‐cause mortality there was little or no difference between flexible sigmoidoscopy and FOBT(Relative risk 0.98; 95% CrI 0.95 to 1.00) using the MTM approach. The relative risk of death from all causes in the screening group was 0.98 (95% CI 0.95 to 1.01) compared to the control group in the flexible sigmoidoscopy trials. In the FOBT studies the relative risk was 1.00 (95% CI 0.99 to 1.01). </p> <p>The rates of major complications in the flexible sigmoidoscopy groups was 8 in 10,000. Although headline rates of major complications were lower in the FOBT studies (3 in 10,000), this was associated with follow‐up investigations, including sigmoidoscopy. </p> </section> <section id="CD009259-sec-0077"> <h3 class="title" id="CD009259-sec-0077">Overall completeness and applicability of evidence</h3> <p>As the sensitivity of the guaiac‐based tests for detecting advanced adenomas is only 16% to 31% (<a href="./references#CD009259-bbs2-0071" title="vanDamL , KuipersEJ , vanLeerdamME . Performance improvements of stool‐based screening tests. Best Practice &amp; Research. Clinical Gastroenterology2010;24(4):479‐92. [PUBMED: 20833351] ">van Dam 2010</a>), no effect on CRC incidence was anticipated. This was indeed true for the Danish (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>), Swedish (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>) and English (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>) FOBT trials where the number of CRCs were almost identical in the screening and control groups. In the US FOBT trial (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>), a statistically significant reduction in new cases of CRC was detected. This was most probably due to the very high rate of colonoscopies performed in this trial, 28% of attenders in the biennial screening group and 38% in the annual screening group. Colonoscopy rates were 4% to 9% in the other FOBT trials. We found a 5% decrease in CRC incidence when FOBT was compared to no screening, but heterogeneity was considerable among the trials. When we removed the US study from the analysis, heterogeneity was reduced to zero and no difference in CRC incidence between the control and screening groups could be detected. </p> <p>In contrast to FOBT, flexible sigmoidoscopy has the ability to detect and remove precursor lesions from the examined part of the intestine. Our meta‐analysis of the five flexible sigmoidoscopy trials showed a statistically significant reduction in new cases of CRC in the entire colon and rectum by 18%. There was considerable heterogeneity between these studies, which was mainly caused by the Norwegian NORCCAP trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>). Removing this trial from the analyses revealed a heterogeneity of 18% (P = 0.3) in the comparison of the remaining trials. The NORCCAP trial (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>) had a very short follow‐up (six to seven years) compared to the other trials (11 to 13 years) and this may be the reason for the heterogeneity. Other reasons, like differences in study design, cannot be ruled out however. </p> <p>One reason why a difference in the incidence of cancer in the colorectum between FOBT and flexible sigmoidoscopy could not be established could be the high colonoscopy rate in the US FOBT trial (<a href="./references#CD009259-bbs2-0019" title="MandelJS , ChurchTR , BondJH , EdererF , GeisserMS , MonginSJ , et al. The effect of fecal occult‐blood screening on the incidence of colorectal cancer. The New England Journal of Medicine2000;343(22):1603‐7. [PUBMED: 11096167] ">Mandel 2000</a>). It has been argued that the reduction in incidence in this study may have been due to chance and caused by the poor specificity of the rehydrated FOBT test used, and not by a high test sensitivity (<a href="./references#CD009259-bbs2-0057" title="LangCA , RansohoffDF . Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?. JAMA1994;271(13):1011‐3. [PUBMED: 8139058] ">Lang 1994</a>), thus the rehydrating guaiac‐based FOBT test is no longer recommended (<a href="./references#CD009259-bbs2-0059" title="LevinB , LiebermanDA , McFarlandB , AndrewsKS , BrooksD , BondJ , et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology2008;134(5):1570‐95. [PUBMED: 18384785] ">Levin 2008</a>). This motivated us to perform the sensitivity analysis in which this study was excluded, showing a 18% reduction in incidence in favour of flexible sigmoidoscopy screening compared with FOBT (95% CrI 0.71 to 0.96). </p> <p>In recent years, evidence of a different biology between proximal and distal CRC has been proposed (<a href="./references#CD009259-bbs2-0051" title="GervazP , BucherP , MorelP . Two colons‐two cancers: paradigm shift and clinical implications. Journal of Surgical Oncology2004;88(4):261‐6. [PUBMED: 15565587] ">Gervaz 2004</a>), and this may have implications for screening. The effect of screening on mortality from proximal versus distal CRC was reported in the Danish and English FOBT trials. No statistically significant differences in protection from right‐ or left‐sided CRC deaths were found, although there was a trend towards a greater reduction in mortality from proximal compared to distal colon cancers. Among the flexible sigmoidoscopy trials, the Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) and US (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>) trials specifically reported an effect of screening on CRC mortality from right‐ compared to left‐sided CRC. In neither of the trials was mortality from right‐sided CRC reduced. The evidence supports the idea of combining the two screening modalities and this issue has been addressed in a number of trials (<a href="./references#CD009259-bbs2-0032" title="BerryDP , ClarkeP , HardcastleJD , VellacottKD . Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. The British Journal of Surgery1997;84(9):1274‐6. [PUBMED: 9313712] ">Berry 1997</a>; <a href="./references#CD009259-bbs2-0037" title="RasmussenM , KronborgO , FengerC , JorgensenOD . Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult‐II in screening for colorectal cancer. A randomized study. Scandinavian Journal of Gastroenterology1999;34(1):73‐8. [PUBMED: 10048736] ">Rasmussen 1999</a>; <a href="./references#CD009259-bbs2-0034" title="DenisB , GendreI , AmanF , RibsteinF , MaurinP , PerrinP . Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac‐based faecal occult blood testing: a French population‐based controlled study (Wintzenheim trial). European Journal of Cancer2009;45(18):3282‐90. [PUBMED: 19665368] ">Denis 2009</a>). These studies indicate that adding flexible sigmoidoscopy to FOBT substantially reduces compliance with screening, but is counter‐balanced by a three to seven times higher diagnostic yield of advanced adenomas despite the lower compliance. Whether the higher rate of advanced adenoma detection and subsequent removal and surveillance translates into lower mortality or incidence of CRC is unknown. </p> <p>Prior case‐control studies have anticipated that endoscopic examination and polypectomy in the distal colon may reduce CRC incidence in this area by 70% to 80% (<a href="./references#CD009259-bbs2-0044" title="AtkinWS , MorsonBC , CuzickJ . Long‐term risk of colorectal cancer after excision of rectosigmoid adenomas. The New England Journal of Medicine1992;326(10):658‐62. [PUBMED: 1736104] ">Atkin 1992</a>; <a href="./references#CD009259-bbs2-0068" title="SelbyJV , FriedmanGD , QuesenberryCPJr , WeissNS . A case‐control study of screening sigmoidoscopy and mortality from colorectal cancer. The New England Journal of Medicine1992;326(10):653‐7. [PUBMED: 1736103] ">Selby 1992</a>; <a href="./references#CD009259-bbs2-0061" title="NewcombPA , StorerBE , MorimotoLM , TempletonA , PotterJD . Long‐term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. Journal of the National Cancer Institute2003;95(8):622‐5. [PUBMED: 12697855] ">Newcomb 2003</a>), but with no reduction in the incidence of CRC located proximal to the sigmoid colon (<a href="./references#CD009259-bbs2-0061" title="NewcombPA , StorerBE , MorimotoLM , TempletonA , PotterJD . Long‐term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. Journal of the National Cancer Institute2003;95(8):622‐5. [PUBMED: 12697855] ">Newcomb 2003</a>). Incidence rates for proximal and distal CRC in the British and Italian trials support these findings. CRC incidence was reduced by 36% and 24% in the distal colon, but only by a non‐significant 2% and 9% in the proximal colon in the two trials, respectively. In the PLCO trial, on the other hand, the CRC incidence was reduced in both the distal colon, by 29%, and the proximal colon, by 14% (both P &lt; 0.05). The anticipated lack of effect on mortality and incidence of right sided colon cancers by flexible sigmoidoscopy has made colonoscopy a gold standard in screening for CRC, despite no evidence of efficacy from prospective trials. Recently, two case‐control studies have questioned the role of colonoscopy role in preventing right‐sided CRC. Prior exposure to colonoscopy was associated with reduced mortality from distal but not proximal CRC in a study from Canada (<a href="./references#CD009259-bbs2-0045" title="BaxterNN , GoldwasserMA , PaszatLF , SaskinR , UrbachDR , RabeneckL . Association of colonoscopy and death from colorectal cancer. Annals of Internal Medicine2009;150(1):1‐8. [PUBMED: 19075198] ">Baxter 2009</a>), and reduced incidence of left‐sided but not right‐sided advanced adenomas was evident in a report from Germany (<a href="./references#CD009259-bbs2-0047" title="BrennerH , HoffmeisterM , ArndtV , StegmaierC , AltenhofenL , HaugU . Protection from right‐ and left‐sided colorectal neoplasms after colonoscopy: population‐based study. Journal of the National Cancer Institute2010;102(2):89‐95. [PUBMED: 20042716] ">Brenner 2010</a>. A third case‐control study from the latter group provided conflicting evidence to the former two, showing a relative risk of 0.44 (95% CI 0.35 to 0.55) for developing proximal CRC in 1688 cases who had had a colonoscopy in the preceding 10 years compared to 1932 matched controls who were unexposed to colonoscopy in the same time period (<a href="./references#CD009259-bbs2-0048" title="BrennerH , Chang‐ClaudeJ , SeilerCM , RickertA , HoffmeisterM . Protection from colorectal cancer after colonoscopy: a population‐based, case‐control study. Annals of Internal Medicine2011;154(1):22‐30. [PUBMED: 21200035] ">Brenner 2011</a>). </p> <p>When comparing flexible sigmoidoscopy and FOBT, time to follow‐up becomes a highly relevant and complex issue. FOBT reduces CRC specific mortality by detecting early stage disease with a favourable prognosis, but new cases (incidence) are not reduced as the sensitivity for precursor lesions is low. This means that after FOBT screening has come to an end, new cases of CRC will develop with the same rate in those previously screened as in the control group. Thus, the protective effect of the screening intervention is no longer present, or at least to a lesser extent, after screening has ceased. This is well demonstrated by the three reports from the English FOBT trial, where screening stopped in February 1995. The first report had a cut‐off for follow‐up three months after the end of screening (<a href="./references#CD009259-bbs2-0004" title="HardcastleJD , ChamberlainJO , RobinsonMH , MossSM , AmarSS , BalfourTW , et al. Randomised controlled trial of faecal‐occult‐blood screening for colorectal cancer. Lancet1996;348(9040):1472‐7. [PUBMED: 8942775] ">Hardcastle 1996</a>), the second at four years (<a href="./references#CD009259-bbs2-0025" title="ScholefieldJH , MossS , SufiF , ManghamCM , HardcastleJD . Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut2002;50(6):840‐4. [PUBMED: 12010887] ">Scholefield 2002</a>) and the third 14 years after screening had ceased (<a href="./references#CD009259-bbs2-0026" title="ScholefieldJH , MossSM , ManghamCM , WhynesDK , HardcastleJD . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61(7):1036‐40. [PUBMED: 22052062] ">Scholefield 2012</a>). The reduction in CRC mortality in favour of the screening group was 15% (95% CI 2% to 26%), 13% (95% CI 3% to 22%) and 9% (95% CI 2% to 16%) in the three reports, respectively. The effect of flexible sigmoidoscopy, on the other hand, seems to be long lasting. After a median of approximately 11 years in the British (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>), Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) and US (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>) flexible sigmoidoscopy screening trials, survival curves of the screening group and control group are still diverging, indicating that the maximum effect of flexible sigmoidoscopy screening has not yet been achieved, and that the mortality rate ratios are still in favour of the screening group (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>). Thus, choosing only the last report from the trials in the MTM analysis, as pre‐specified in our protocol, may not provide the right answer. The 10‐year sensitivity analysis included the first reports after FOBT screening had stopped and should thus include the maximum effect of the FOBT screening intervention. In addition, times to follow‐up are more similar in the flexible sigmoidoscopy trials. In this analysis, the incidence of CRC was reduced when flexible sigmoidoscopy screening was compared to FOBT, while there was a trend towards reduced mortality from CRC when flexible sigmoidoscopy screening was compared to FOBT; the credibility interval of the latter analysis just crossed 1. </p> <p>When policymakers consider the implementation of a screening program for colorectal cancer, they should base their judgement on high‐quality evidence that is applicable to their population and setting. Much of the evidence in this review is of high quality, but the applicability of the findings to a real‐life screening programme may be questioned due to how some of the studies were designed. The only true population‐based trials mimicking a screening programme are the English FOBT trial (<a href="./references#CD009259-bbs2-0025" title="ScholefieldJH , MossS , SufiF , ManghamCM , HardcastleJD . Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut2002;50(6):840‐4. [PUBMED: 12010887] ">Scholefield 2002</a>) and the Norwegian NORCCAP study (<a href="./references#CD009259-bbs2-0007" title="HoffG , GrotmolT , SkovlundE , BretthauerM . Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (Clinical research ed.)2009;338:b1846. [PUBMED: 19483252] ">Hoff 2009</a>). All other trials applied study designs which impair applicability. The two US trials, (<a href="./references#CD009259-bbs2-0024" title="SchoenR , PinskyP , WeissfieldJ , YokochiL , ChurchT , LaiyemoA , et al. Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. The New England Journal of Medicine2012;366:2345‐57. [PUBMED: 22612596] ">Schoen 2012</a>; <a href="./references#CD009259-bbs2-0017" title="MandelJS , BondJH , ChurchTR , SnoverDC , BradleyGM , SchumanLM , et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England Journal of Medicine1993;328(19):1365‐71. [PUBMED: 8474513] ">Mandel 1993</a>), the British (<a href="./references#CD009259-bbs2-0002" title="AtkinWS , EdwardsR , Kralj‐HansI , WooldrageK , HartAR , NorthoverJM , et al. Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375(9726):1624‐33. [PUBMED: 20430429] ">Atkin 2010</a>) and Italian (<a href="./references#CD009259-bbs2-0028" title="SegnanN , ArmaroliP , BonelliL , RisioM , ScialleroS , ZappaM , et al. Once‐only sigmoidoscopy in colorectal cancer screening: Follow‐up findings of the Italian randomized controlled trial‐‐SCORE. Journal of the National Cancer Institute2011;103(17):1310‐22. [PUBMED: 21852264] ">Segnan 2011</a>) trials recruited volunteers to participate in the studies. This design increases statistical power, but the effect on the population level may be overestimated. In Denmark (<a href="./references#CD009259-bbs2-0012" title="KronborgO , JorgensenOD , FengerC , RasmussenM . Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scandinavian Journal of Gastroenterology2004;39(9):846‐51. [PUBMED: 15513382] ">Kronborg 2004</a>), only those participating in the preceding screening round were invited for the next, which may underestimate the screening effect on the population level. The three cohorts in the Swedish trial (<a href="./references#CD009259-bbs2-0016" title="LindholmE , BrevingeH , HaglindE . Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. The British Journal of Surgery2008;95(8):1029‐36. [PUBMED: 18563785] ">Lindholm 2008</a>) were offered only a limited number of screening rounds with FOBT, and the small Norwegian TPS study (<a href="./references#CD009259-bbs2-0030" title="Thiis‐EvensenE , HoffGS , SauarJ , LangmarkF , MajakBM , VatnMH . Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology1999;34(4):414‐20. [PUBMED: 10365903] ">Thiis‐Evensen 1999</a>) suffered from a potentially biased randomisation sequence procedure. Thus, results from the individual studies should be interpreted with these points in mind. </p> <p>We did not detect any reduction in all‐cause mortality for either screening test. This is an expected finding as CRC is a quite rare cause of death. To show an effect of CRC screening on all‐cause mortality, a very large number of individuals would have to be included, and the present studies are underpowered to detect a difference regarding this endpoint. </p> <p>An evaluation of costs of screening was beyond the scope of this review. Many cost‐benefit analyses have been performed in the CRC screening setting. Neither flexible sigmoidoscopy nor FOBT has been proven to be superior to the other. In addition, these analyses are based on numerous assumptions, which may differ substantially between countries and make it not possible to generalize results across the borders (<a href="./references#CD009259-bbs2-0058" title="Lansdorp‐VogelaarI , KnudsenAB , BrennerH . Cost‐effectiveness of colorectal cancer screening ‐ an overview. Best Practice &amp; Research. Clinical Gastroenterology2010;24(4):439‐49. [PUBMED: 20833348] ">Lansdorp‐Vogelaar 2010</a>). </p> </section> <section id="CD009259-sec-0078"> <h3 class="title" id="CD009259-sec-0078">Potential biases in the review process</h3> <p>The MTM is based on the use of both indirect and direct evidence for estimation of the difference between two interventions (in this review: screening methods). In our specific case, we did not find any head‐to‐head comparisons of flexible sigmoidoscopy versus faecal occult blood testing (FOBT). As a consequence, the results regarding this comparison are based on indirect evidence only. The validity of our results for the comparison of flexible sigmoidoscopy versus FOBT thus depends heavily on the assumption that the common comparator (no screening) arms in the included studies are sufficiently similar. Data were scarce in the included studies regarding important demographic variables such as ethnicity, smoking history, level of education and physical activity. To judge comparability, we scrutinized the exclusion criteria in the individual studies and the incidence and mortality rates in the control groups, see <a href="./references#CD009259-sec-0110" title="">Characteristics of included studies</a>, <a href="#CD009259-tbl-0005">Table 4</a>, <a href="#CD009259-tbl-0006">Table 5</a>. Even if some differences exist, we think that these do not undermine our assumption of comparability, but with no direct evidence for the flexible sigmoidoscopy versus FOBT comparison it is impossible for us to quantity the inconsistency in the system. </p> <div class="table" id="CD009259-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Mortality rates in screening and control groups</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                       Screening group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                        Control group      </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio (95% CI)</b> </p> <p><b> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Screening modality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths/100000py</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths (n)    </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths/100000py</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US (annual)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>237420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.68 (0.54‐0.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US</p> <p>(biennial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>237420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (0.66‐1.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1296712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1296614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.84‐0.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>430755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.73‐0.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.71‐0.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK          </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620045</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1224523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.59‐0.82)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>868966*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>874358*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (0.63‐0.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186745</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (0.57‐1.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway</p> <p>(NORCCAP)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73 (0.47‐1.14)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33 (0.03‐3.18)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Mortality rates in screening and control groups, NR: Not reported; gFOBT: guaiac faecal occult blood test; FS: Flexible sigmoidoscopy; py: person year; US: United States; UK: United Kingdom. *Estimated numbers. </p> </div> </div> <div class="table" id="CD009259-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Incidence rates in screening and control groups</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                       Screening group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                        Control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Screening modality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>  Cases (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases/100000py</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases (n)    </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases/100000py</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US (annual)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>417</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>232612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>507</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (0.72‐0.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US</p> <p>(biennial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>232612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>507</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.75‐0.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1286526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 2279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1286877</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97 (0.91‐1.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>889</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>430755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.93‐1.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>721</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.10 (0.99‐1.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK          </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620045</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1224523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (0.70‐0.84)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>850420*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846710*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (0.72‐0.85)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.70‐0.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (NORCCAP)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91449*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274242*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.83‐1.25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.04‐0.90)<sup>**</sup> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Incidence rates in screening and control groups. *Estimated numbers; **From publication; gFOBT: guaiac faecal occult blood test; FS: Flexible sigmoidoscopy; py:person year; CI: Confidence interval; US: United States; UK: United Kingdom; NR: Not reported. </p> </div> </div> <p>One should also be aware of the fact that our analyses are by intention to treat. This means that we compared screening programmes including flexible sigmoidoscopy or FOBT and not the screening modalities as such. In other words, we assessed the impact of screening at the population level, which takes into account the degree to which individuals choose to attend screening or not. The effect of screening among those who decided to take part in the programme ('efficacy') may be different than our effect estimates. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009259-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/urn:x-wiley:14651858:media:CD009259:CD009259-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_t/tCD009259-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD009259-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009259-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/urn:x-wiley:14651858:media:CD009259:CD009259-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_t/tCD009259-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009259-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009259-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/urn:x-wiley:14651858:media:CD009259:CD009259-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_t/tCD009259-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Screening procedures versus control ‐ all studies, Outcome 1 Colorectal cancer mortality." data-id="CD009259-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Screening procedures versus control ‐ all studies, Outcome 1 Colorectal cancer mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/references#CD009259-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009259-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/urn:x-wiley:14651858:media:CD009259:CD009259-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_t/tCD009259-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Screening procedures versus control ‐ all studies, Outcome 2 Colorectal cancer incidence." data-id="CD009259-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Screening procedures versus control ‐ all studies, Outcome 2 Colorectal cancer incidence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/references#CD009259-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009259-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/urn:x-wiley:14651858:media:CD009259:CD009259-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_t/tCD009259-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Screening procedures versus control ‐ all studies, Outcome 3 All‐cause Mortality." data-id="CD009259-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Screening procedures versus control ‐ all studies, Outcome 3 All‐cause Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/references#CD009259-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/media/CDSR/CD009259/image_n/nCD009259-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009259-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Screening for colorectal cancer with flexible sigmoidoscopy or faecal occult blood test</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Flexible sigmoidoscopy or faecal occult blood testing compared with care as usual for colorectal cancer screening</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: Asymptomatic individuals</b> </p> <p><b>Settings: Participants recruited among volunteers or randomly chosen from public registries</b> </p> <p><b>Intervention: Flexible sigmoidoscopy once only or repeated faecal occult blood testing</b> </p> <p><b>Comparison: Care as usual</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks<sup>1</sup> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No screening</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Screening group</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC Mortality ‐ Flexible sigmoidoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> <br/> (5 to 6) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,72</b> (0.65 to 0.79) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414,744<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC Mortality ‐ Faecal occult blood testing</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> <br/> (6 to 7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,86</b> (0.80 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329,642<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC incidence ‐ Flexible sigmoidoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> <br/> (15 to 18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,82</b> (0.73 to 0.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414,744<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CRC incidence ‐ Faecal occult blood testing</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (18 to 20 ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,95</b> (0,88 to 1,02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329,536<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause Mortality ‐ Flexible sigmoidoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>254 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>249 per 1000</b> <br/> (241 to 257 ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0,98</b> (0.95 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>364,827<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause Mortality ‐ Faecal occult blood testing</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>254 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>254 per 1000</b> <br/> (251 to 257) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1,00</b> (0,99 to 1,01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329,642<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>CRC:</b> Colorectal cancer </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Assumed risk is computed by combining events and participants in the control groups in all trials. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). </p> <p><sup>2</sup> Evidence downgraded one level due to heterogeneity between trials. This heterogeneity may be explained by shorter follow‐up of the Norwegian NORCCAP trial, but other explanations like study design cannot be ruled out. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Screening for colorectal cancer with flexible sigmoidoscopy or faecal occult blood test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009259-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screening</b> </p> <p><b>modality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control group (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screening group (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Men/Women (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Compliance<sup>+</sup>  (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> <p><b>(years)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Volunteers</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1975‐1992*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A:15570</p> <p>B:15587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22367/24184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A: 90</p> <p>B: 90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1981‐1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72172/78079<sup>++</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 11.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1985‐2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30966</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30967</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29714/32219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1982‐1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 15.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United Kingdom</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Volunteers</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1994‐1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112939</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57099</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83331/86707</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 11.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Volunteers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1993‐2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55‐74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77455</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76684/78216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Single: 87</p> <p>Dual: 51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality:</p> <p>median 12.1</p> <p>Incidence:</p> <p>median 11.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Volunteers</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1995‐1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17234/17168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality:</p> <p>median 11.4</p> <p>Incidence:</p> <p>median 10.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (NORCCAP)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1999‐2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41092</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13653</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%**</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality:  </p> <p>Median 6</p> <p>Incidence:</p> <p>median 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway</p> <p>(TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Population based</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400/399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>Characteristics of included studies. *Hiatus in screening 1982‐1986, ** Actual figures not reported, A: Annual screening, B: Biennial screening, NR: Not reported, gFOBT: guaiac faecal occult blood test. FS: Flexible Sigmoidoscopy <sup>+</sup>At least 1 round in FOBT trials, <sup>++</sup>Sum of men and women  does not equal sum of screening and control group due to difference in reporting, please see characteristics of included studies for further explanation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009259-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Histologic classification of colorectal cancers in the screening and control groups</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Screening group</b> </p> <p><b>Duke classification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Control group</b> </p> <p><b>Duke classification</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>A</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>B</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>C</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>D</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>A</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>B</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>C</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>D</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>FOBT trials</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States</p> <p>(annual screening)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107/354 (30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101/354 (29%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80/354 </p> <p>(23%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33/354</p> <p>(9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88/394</p> <p>(22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120/394 (30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82/394</p> <p>(21 %)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65/394</p> <p>(17%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States</p> <p>(biennial screening)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98/368</p> <p>(27%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95/368</p> <p>(26%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100/368 (27%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41/368</p> <p>(11%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88/394</p> <p>(22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120/394 (30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82/394</p> <p>(21%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65/394</p> <p>(17%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181/893 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286/893 (32%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>215/893 (24%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>192/893 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95/856</p> <p>(11%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>285/856 (33%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264/856 (31%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>179/856 (21%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105/481 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164/481 (34%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90/481</p> <p>(19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98/481</p> <p>(20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54/483</p> <p>(11%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177/483 (37%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111/483 (23%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114/483 (24%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124/721 (17%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>261/721 (36%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184/721 (26%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152/721 (21%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112/754 (15%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>260/721 (35%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>221/754 (29%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>161/754 (21%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>Flexible sigmoidoscopy trials</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United Kingdom           </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>NR </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>574/955</p> <p>(60%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>381/955</p> <p>(40%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>716/1253</p> <p>(57%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>537/1253</p> <p>(43%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy*</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>139/251</p> <p>(55%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>112/251</p> <p>(45%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>154/306</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>152/306</p> <p>(50%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway<sup>+</sup> (NORCCAP) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>33/123</p> <p>(27%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>78/123</p> <p>(63%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>62/362</p> <p>(17%)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>262/362</p> <p>(72%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norway (TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/2</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/2</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/10</p> <p>(50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/10</p> <p>(30%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/10</p> <p>(20%)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Stages of colorectal cancers diagnosed in the screening and control groups. *Cancers classified according to the Union for International Cancer Control as non‐advanced (Stage I and II) or advanced (Stage III and IV). Non‐advanced cancers equals Duke A and B. Advanced cancers equals Duke C and D. <sup>+</sup>The Norwegian NORCCAP trial classified cancers according to a modified Duke classification system. Duke A and B cancers were classified as “localized”, but Duke B cancers infiltrating neighbouring organs without distant metastasis were classified as “advanced”. NR: Not reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Histologic classification of colorectal cancers in the screening and control groups</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009259-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Physical complications to screening</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Flexible sigmoidoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Colonoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bleeding<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Perforation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death&lt;30days of procedure<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death &lt;30 days</b> </p> <p><b>of surgery</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major complications<sup>3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Miscellaneous</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United States (gFOBT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>United States</p> <p>(FS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England (gFOBT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 <sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1<sup>5</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Sweden (gFOBT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> 14<sup>15</sup> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Norway (FS, NORCCAP)<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2524</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>United Kingdom (FS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40332<sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12<sup>9</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 <sup>10</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 <sup>11</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3<sup>12</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13<sup>13</sup> </p> <p>172<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 <sup>14</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 7<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy (FS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9911</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>775</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<sup>7</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Norway (FS, TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TOTAL</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>172871</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>4</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>3</b> </p> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> <b>376</b> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>37560</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>27</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5</b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup> Those admitted to hospital due to bleeding </p> <p><sup>2</sup> Death within 30 days of endoscopic screening or work‐up </p> <p><sup>3</sup> Bleeding, perforation and death excluded </p> <p><sup>4</sup> Myocardial infarction, 1 anastomotic leak, 2 pulmonary embolus, 1 carcinomatosis </p> <p><sup>5</sup> Snare entrapment </p> <p><sup>6</sup> Includes individuals aged 50‐64 years </p> <p><sup>7</sup> Minor events not requiring hospitalisation </p> <p><sup>8</sup> 342 individuals had a baseline colonoscopy screening procedure due to strong family history of CRC and is included in the colonoscopy figures </p> <p><sup>9</sup>  Includes 3 individuals with glutaraldehyde colitis </p> <p><sup>10</sup> 3 myocardial infarction, 1 cardiomyopathy, 1 intracerebral haemorrhage, 1 lung cancer </p> <p><sup>11</sup> 2 cardiovascular, 1 respiratory, 1 septicaemia </p> <p><sup>12</sup> 2 myocardial infarction, 1 pulmonary embolus </p> <p><sup>13</sup> 5 cases of definite glutaraldehyde colitis and 8 probable cases </p> <p><sup>14</sup> Myocardial infarction </p> <p><sup>15</sup> 14 patients who had a laparotomy had complications which prolonged their hospital stay </p> <p>FS: Flexible sigmoidoscopy. gFOBT: Faecal occult blood test. NORCCAP: Norwegian colorectal cancer prevention trial. TPS: Telemark polyp study </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Physical complications to screening</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009259-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Mortality rates in screening and control groups</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                       Screening group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                        Control group      </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio (95% CI)</b> </p> <p><b> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Screening modality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths/100000py</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths (n)    </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Deaths/100000py</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US (annual)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>237420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.68 (0.54‐0.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US</p> <p>(biennial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>237420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (0.66‐1.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1296712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1296614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.84‐0.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>430755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.73‐0.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.71‐0.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK          </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620045</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1224523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.59‐0.82)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>868966*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>874358*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (0.63‐0.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186745</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (0.57‐1.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway</p> <p>(NORCCAP)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73 (0.47‐1.14)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33 (0.03‐3.18)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Mortality rates in screening and control groups, NR: Not reported; gFOBT: guaiac faecal occult blood test; FS: Flexible sigmoidoscopy; py: person year; US: United States; UK: United Kingdom. *Estimated numbers. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Mortality rates in screening and control groups</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009259-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Incidence rates in screening and control groups</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                       Screening group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>                        Control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Screening modality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>  Cases (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases/100000py</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Personyear</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases (n)    </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases/100000py</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US (annual)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>417</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>232612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>507</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (0.72‐0.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US</p> <p>(biennial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>232612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>507</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.75‐0.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>England</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1286526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 2279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1286877</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97 (0.91‐1.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>889</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>430755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.93‐1.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gFOBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>721</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.10 (0.99‐1.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK          </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620045</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1224523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (0.70‐0.84)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>850420*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846710*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (0.72‐0.85)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.70‐0.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (NORCCAP)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91449*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274242*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.83‐1.25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Norway (TPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.04‐0.90)<sup>**</sup> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Incidence rates in screening and control groups. *Estimated numbers; **From publication; gFOBT: guaiac faecal occult blood test; FS: Flexible sigmoidoscopy; py:person year; CI: Confidence interval; US: United States; UK: United Kingdom; NR: Not reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Incidence rates in screening and control groups</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/full#CD009259-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009259-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Screening procedures versus control ‐ all studies</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Colorectal cancer mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Flexible sigmoidoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>414754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.65, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Faecal occult blood testing ‐ all studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329642</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.82, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Faecal occult blood testing ‐ biennial screening only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.81, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Colorectal cancer incidence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Flexible sigmoidoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>414754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.74, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Faecal occult blood testing ‐ all studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.88, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Faecal occult blood testing ‐ biennial testing only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.90, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 All‐cause Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Flexible sigmoidoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.95, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Faecal occult blood testing ‐ all studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329642</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.99, 1.01]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Screening procedures versus control ‐ all studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009259.pub2/references#CD009259-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009259.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009259-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009259-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009259-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD009259-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pl#CD009259-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009259-note-0001">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009259\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009259\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009259\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009259\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009259\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1pyM3CVc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009259.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009259.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009259.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009259.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009259.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740713757911"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009259.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740713757917"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009259.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d5e135993936e',t:'MTc0MDcxMzc1OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 